1. Field
The present application relates generally to electrosurgical systems and methods. More specifically, the present application relates to determination of an electrosurgery endpoint using phase shift monitoring.
2. Discussion of the Relevant Art
Surgical procedures often involve cutting and connecting bodily tissue including organic materials, musculature, connective tissue and vascular conduits. For centuries, sharpened blades and sutures have been mainstays of cutting and reconnecting procedures. As bodily tissue, especially relatively highly vascularized tissue is cut during a surgical procedure, it tends to bleed. Thus, medical practitioners such as surgeons have long sought surgical tools and methods that slow or reduce bleeding during surgical procedures.
More recently, electrosurgical tools have become available that use electrical energy to perform certain surgical tasks. Typically, electrosurgical tools are hand tools such as grapsers, scissors, tweezers, blades, needles, and other hand tools that include one or more electrodes that are configured to be supplied with electrical energy from an electrosurgical generator including a power supply. The electrical energy can be used to coagulate, fuse, or cut tissue to which it is applied. Advantageously, unlike typical mechanical blade procedures, application of electrical energy to tissue tends to stop bleeding of the tissue.
Electrosurgical tools typically fall within two classifications: monopolar and bipolar. In monopolar tools, electrical energy of a certain polarity is supplied to one or more electrodes on the tool. A separate return electrode is electrically coupled to a patient. Monopolar electrosurgical tools can be useful in certain procedures, but can include a risk of certain types of patient injuries such as electrical burns often at least partially attributable to functioning of the return electrode. In bipolar electrosurgical tools, one or more electrodes is electrically coupled to a source of electrical energy of a first polarity and one or more other electrodes is electrically coupled to a source of electrical energy of a second polarity opposite the first polarity. Thus, bipolar electrosurgical tools, which operate without separate return electrodes, can deliver electrical signals to a focused tissue area with a reduced risk of patient injuries.
Even with the relatively focused surgical effects of bipolar electrosurgical tools, however, surgical outcomes are often highly dependent on surgeon skill. For example, thermal tissue damage and necrosis can occur in instances where electrical energy is delivered for a relatively long duration or where a relatively high-powered electrical signal is delivered even for a short duration. The rate at which a tissue will achieve the desired coagulation or cutting effect upon the application of electrical energy varies based on the tissue type and can also vary based on pressure applied to the tissue by an electrosurgical tool. However, even for a highly experienced surgeon, it can be difficult for a surgeon to assess how quickly a mass of combined tissue types grasped in an electrosurgical instrument will be fused a desirable amount.
Attempts have been made to reduce the risk of tissue damage during electrosurgical procedures. For example, previous electrosurgical systems have included generators that monitor an ohmic resistance or tissue temperature during the electrosurgical procedure, and terminated electrical energy once a predetermined point was reached. However, these systems have had shortcomings in that they have not provided consistent results at determining tissue coagulation, fusion, or cutting endpoints for varied tissue types or combined tissue masses. These systems can also fail to provide consistent electrosurgical results among use of different tools having different tool and electrode geometries. Typically, even where the change is a relatively minor upgrade to tool geometry during a product's lifespan, the electrosurgical generator must be recalibrated for each tool type to be used, a costly, time consuming procedure which can undesirably remove an electrosurgical generator from service.
In view of at least the foregoing shortcomings of the previous electrosurgical systems, there is a need in the art to improve control of electrosurgical procedures to enhance consistency of electrosurgical results among electrosurgical tools and tissue types. Accordingly, there is a need for an improved electrosurgical system that can accurately assess an electrical energy application endpoint for a desired electrosurgical procedure. There is also a need for an electrosurgical system that monitors tissue properties during the electrosurgical procedure to assess the energy application endpoint. There is also a need for an improved electrosurgical system that can rapidly accommodate various electrosurgical tools with minimal impact on surgical outcome. To address some or all of these needs and provide various additional advantages as discussed below in greater detail, various embodiments, methods, systems, and apparatuses for electrosurgical procedures are provided.
In various embodiments, methods and apparatuses for bloodless dissection of connective and vascular tissue are provided. The various methods and apparatuses described herein can be used in minimally invasive surgery, particularly laparoscopic surgery.
In certain embodiments, an electrosurgical tool comprises a handle assembly, an elongate shaft, a jaw assembly, and a force regulation mechanism. The handle assembly comprises a stationary handle and an actuation handle movably coupled to the stationary handle. The elongate shaft extends distally from the handle. The elongate shaft has a proximal end and a distal end defining a central longitudinal axis therebetween. The jaw assembly is positioned on the distal end of the elongate shaft. The jaw assembly comprises a first jaw and a second jaw. The first jaw has an inner surface, an outer surface, and at least one electrode disposed on the inner surface. The second jaw has an inner surface, an outer surface, and at least one electrode disposed on the inner surface. The jaw assembly is actuatable by movement of the ff from an open configuration in which the inner surface of the first jaw is spaced apart from the inner surface of the second jaw to a closed configuration in which the inner surface of the first jaw is proximate the inner surface of the second jaw. The force regulation mechanism couples the handle assembly to the jaw assembly. The force regulation assembly is configured such that in the closed configuration, the jaw assembly delivers a gripping force between the first jaw and the second jaw between a predetermined minimum force and a predetermined maximum force.
In other embodiments, an electrosurgical tool is provided comprising a handle assembly, an elongate shaft, and a jaw assembly. The handle assembly comprises a moveable actuation handle. The elongate shaft extends distally from the handle. The elongate shaft has a proximal end and a distal end defining a central longitudinal axis therebetween. The jaw assembly is positioned on the distal end of the elongate shaft. The jaw assembly comprises a first jaw, a second jaw, and a blade. The first jaw has an inner surface, an outer surface, a proximal end and a distal end, and at least one electrode disposed on the inner surface. The second jaw has an inner surface, an outer surface, a proximal end and a distal end and at least one electrode disposed on the inner surface. The blade is advanceable along the inner surface of the first jaw along a cutting path defined between a retracted position adjacent the proximal end and an advanced position between the proximal end and the distal end. The jaw assembly is actuatable from an open configuration to a closed configuration by movement of the actuation handle. The at least one electrode on the first jaw and the at least one electrode on the second jaw define a sealing area enclosing the cutting path of the blade.
In other embodiments, an electrosurgical tool is provided comprising a handle assembly, an elongate shaft, and a jaw assembly. The elongate shaft extends distally from the handle assembly. The shaft having a proximal end and a distal end defining a central longitudinal axis therebetween. The jaw assembly is positioned on the distal end of the elongate shaft. The jaw assembly comprises a first jaw and a second jaw. The first jaw has an inner surface, an outer surface, a proximal end and a distal end, and at least one fusion electrode disposed on the inner surface. The second jaw has an inner surface, an outer surface, a proximal end and a distal end and at least one fusion electrode disposed on the inner surface and a cutting electrode disposed on the outer surface.
In certain embodiments, an electrosurgical system for performing surgical procedures on body tissue of a patient comprises an electrosurgical generator and an electrosurgical tool. The electrosurgical tool comprises a memory module storing tool data. The electrosurgical generator is configured to receive the tool data from the memory module and apply an electrosurgical signal profile to the electrosurgical tool based on the tool data.
In other embodiments, an electrosurgical generator for performing surgical procedures on body tissue of a patient comprises a power supply, a signal generation module, and a first tool port. The signal generation module is electrically coupled to the power supply. The signal generation module is configured to generate a radiofrequency signal. The first tool port is configured to interface with an electrosurgical tool having tool data stored therein. The first tool port is adapted to receive the tool data stored on the electrosurgical tool and to supply the radiofrequency signal from the signal generation module to the tool.
In some embodiments, a controller for electrosurgical tools comprises a first actuator, a second actuator, and a tool selector. The first actuator is movable between an on position and an off position for actuating a first electrosurgical action when in the on position. The second actuator is movable between an on position and an off position for actuating a second electrosurgical action when in the on position. The tool selector has a first state wherein the controller is adapted to be operatively coupled to a first electrosurgical tool and a second state wherein the controller is adapted to be operatively coupled to a second electrosurgical tool.
In certain embodiments, a surgical tool can comprise jaw elements having a plurality of electrodes to be used for both electrosurgical coagulation and cutting. The electrodes can be powered in a first configuration to provide coagulation—leading to hemostasis of small vascular vessels and tissue—and powered in a second configuration for electrosurgical cutting of the coagulated tissue. The two powered configurations can be generated by addressing different electrodes on the jaw elements and applying them with voltages appropriate for electrosurgical coagulation and/or cutting. In some embodiments, the surgical tool can initially be powered in the first configuration to provide coagulation, and then can be powered in the second configuration for electrosurgical cutting. In other embodiments, the electrosurgical tool can be powered only in a coagulating configuration to achieve tissue hemostasis, only in a cutting configuration to dissect tissue, or in a cutting configuration followed by a coagulation configuration.
At the same time, various embodiments of the surgical tools described herein can include different electrode configurations. I.e., while in one embodiment only the lower jaw is utilized to provide both coagulation and cutting functions, another embodiment can also employ the upper jaw element to be used in the coagulation and/or cutting process. In yet another embodiment, each jaw element can carry multiple electrode elements, greatly increasing the functionality of the tool. A specific electrode arrangement can allow for tools that are more suitable for particular surgical procedures.
Another aspect of the surgical tools described herein relates to activation and deactivation of one or multiple electrodes, based on the position of the jaw elements. This position-based actuation allows, for example, activation of the upper jaw electrodes only in a near-closed position of the tool (or, in other embodiments, in an opened or near-opened position of the tool). In some embodiments, electrical switches in the jaw element driving mechanism can be positioned in a hand-piece of the surgical tool to selectively activate and deactivate one or multiple electrodes based on a position of the jaw elements. In other embodiments, the activation and deactivation can be performed by sliding contacts that are assembled in the hand-piece.
Yet another aspect of the surgical tools described herein is the automated switching from coagulation to cutting, enabled by use of a multi-electrode generator. Here, a tissue feedback mechanism triggers both switching from one set of coagulation electrodes (applied with voltages appropriate for coagulation) to another set of cutting electrodes (applied with voltages appropriate for cutting). As such, each individual tool electrode can be relayed through a bus-bar connection to any polarity of choice of the power supply. In addition, tool position switches in the hand tool can provide with logic switching for the population of different coagulation and/or cutting settings, depending on the specific tool position.
In certain embodiments, an electrosurgical tool is provided comprising a first jaw, a second jaw, a first electrode, a second electrode, and a third electrode. The second jaw is pivotable with respect to the first jaw. The first electrode is positioned on the first jaw. The second electrode is positioned on the first jaw. The third electrode is positioned on the first jaw. The electrosurgical tool can be selectively configurable in a coagulation configuration such that at least one of the first, second, and third electrodes is electrically coupled with a source of electrical energy having a first polarity and at least one other of the electrodes is electrically coupled with a source of electrical energy having a second polarity generally opposite the first polarity and in a cutting configuration such that one of the first, second, and third electrodes is electrically coupled with a source of electrical energy having a cutting voltage and at least one other of the electrodes is configured to be a return electrode.
In other embodiments, an electrosurgical tool having a proximal end and a distal end is provided comprising a distal end-piece, an elongate shaft, a handle assembly, and a switching mechanism. The distal end-piece is positioned at the distal end of the tool. The distal end-piece comprises a first jaw element, a second jaw element, and a plurality of electrodes. The first and second jaw elements are movable relative to one another between an open position and a closed position. The plurality of electrodes is disposed on at least one of the first jaw element and the second jaw element. The plurality of electrodes is selectively configurable in one of a coagulation configuration and a cutting configuration. The elongate shaft has a distal end connected to the distal end-piece and a proximal end. The handle assembly is positioned at the proximal end of the tool and connected to the proximal end of the elongate shaft. The handle assembly comprises a hand-piece and a trigger. The trigger is pivotally coupled to the hand-piece and operably coupled to the distal end-piece such that movement of the trigger relative to the hand-piece moves the first and second jaw elements relative to one another. The switching mechanism is electrically coupled to the distal end-piece to selectively configure the plurality of electrodes in one of the coagulation configuration and the cutting configuration.
In other embodiments, a method for substantially bloodless dissection of biological tissue is provided. The method comprises positioning an electrosurgical tool adjacent tissue to be dissected, measuring tissue properties to determine the switching point from coagulation to cutting, applying electrical energy to the electrosurgical tool, assessing the tissue coagulation (phase shift) through a feedback loop, switching a configuration of the electrosurgical tool, and applying electrical energy to the electrosurgical tool in a cutting configuration. The electrosurgical tool comprises a plurality of electrodes configurable in one of a coagulation configuration and a cutting configuration. Applying electrical energy to the electrosurgical tool comprises applying electrical energy to the electrosurgical tool in the coagulation configuration to achieve hemostasis in the tissue. Switching the electrosurgical tool comprises switching the electrosurgical tool to the cutting configuration.
In some embodiments, a method for controlling an output of an electrosurgical generator operatively coupled to a bipolar electrosurgical device is provided. The method comprises measuring a phase angle, determining a target phase angle, measuring the phase angle of a second measurement signal, and ceasing delivery of a treatment signal. Measuring the phase angle comprises measuring a phase angle of a first measurement signal applied to tissue of a patient via at least one electrode of the electrosurgical device. The first measurement signal is applied to the tissue prior to treatment of the tissue by the electrosurgical device. Determining a target phase angle comprises determining a target phase angle using the phase angle of the first measurement signal. Following delivery of a treatment signal comprises following delivery of a treatment signal to the tissue. Measuring the phase angle of a second measurement signal comprises measuring the phase angle of a second measurement signal applied to the tissue. The treatment signal is capable of causing modification of the tissue. Ceasing delivery of the treatment signal comprises ceasing delivery of the treatment signal to the tissue when the phase angle of the second measurement signal reaches the target phase angle.
In other embodiments, a method for controlling an output of an electrosurgical generator operatively coupled to a bipolar electrosurgical device is provided. The method comprises determining permittivity and conductivity of tissue, determining a threshold phase angle, measuring a phase angle, and ceasing the delivery of the treatment signal. Determining permittivity and conductivity of tissue comprises determining permittivity and conductivity of tissue of a patient using a measurement signal. The measurement signal is applied to tissue of a patient via at least one electrode of the electrosurgical device. The measurement signal is applied to the tissue prior to modification of the tissue by the electrosurgical device. Determining a threshold phase angle comprises determining a threshold phase angle based on the permittivity and the conductivity of the tissue. Measuring a phase angle comprises measuring a phase angle of a signal applied to the tissue. Ceasing the delivery of the treatment signal comprises ceasing the delivery of the treatment signal to the tissue when the phase angle of the signal reaches the threshold phase angle.
In other embodiments, a method of characterizing tissue prior to the delivery of electrosurgical energy to the tissue via a bipolar electrosurgical device is provided. The method comprises measuring phase angle, determining the product of the relative permittivity and conductivity, and characterizing the tissue. Measuring phase angle comprises measuring phase angle of a measurement signal applied to tissue of a patient via at least one electrode of the electrosurgical device. The measurement signal is applied to the tissue at a predetermined frequency prior to modification of the tissue by the electrosurgical device. Determining the product of the relative permittivity and conductivity comprises determining the product of the relative permittivity and conductivity of the tissue using the phase angle measurement and the predetermined frequency. Characterizing the tissue comprises characterizing the tissue based on the product of the relative permittivity and conductivity of the tissue.
In other embodiments, a method of characterizing tissue prior to the delivery of electrosurgical energy to the tissue via a bipolar electrosurgical device is provided. The method comprises generating a measurement signal, determining a treatment endpoint condition, and stopping delivery of a treatment signal. Generating a measurement signal comprises generating a measurement signal applied to tissue of a patient positioned between at least two jaw members of an electrosurgical device. At least one of the jaw members comprises an electrode. The measurement signal is delivered to the tissue via the electrode and applied to modification of the tissue by the electrosurgical device. Determining a treatment endpoint condition comprises determining a treatment endpoint condition using the measurement signal. The treatment endpoint condition is determined substantially independently of the dimensions of the tissue positioned between the at least two jaw members. Stopping delivery of a treatment signal comprises stopping delivery of a treatment signal to the tissue when the treatment endpoint condition is reached. The treatment signal is capable of causing modification of the tissue.
In other embodiments, an electrosurgical system for application of treatment energy to a patient involved in bipolar electrosurgery is provided. The system comprises an electrosurgical generator, an electrosurgical control unit, and an electrosurgical tool. The electrosurgical generator is configured to generate and output a treatment energy along with a measurement signal. The electrosurgical control unit is configured to direct the output of treatment energy and a measurement signal. The electrosurgical tool is removably connected to one of the electrosurgical generator and the electrosurgical control unit and arranged to contact tissue and apply the treatment energy and the measurement signal to the tissue. The electrosurgical control unit measures permittivity and conductivity of the tissue through the application of the measurement signal.
The present inventions may be understood by reference to the following description, taken in connection with the accompanying drawings in which the reference numerals designate like parts throughout the figures thereof.
a is an enlarged perspective view of a clamping jaw showing a plurality of current intensifying elements comprising extended arcs.
b is an enlarged perspective view of a clamping jaw showing a plurality of current intensifying elements comprising extended squares.
c is an enlarged perspective view of a clamping jaw showing a plurality of current intensifying elements comprising extended rods.
d is an enlarged perspective view of a clamping jaw showing a plurality of current intensifying elements comprising extended “ball-and-cups”.
a is an enlarged perspective view of a clamping jaw showing a plurality of current intensifying elements comprising extended ridges.
a and b are views of an exemplary portion of an artery sealed and cut (108a top plan view, 108b along 8-8).
a and b are views of an exemplary portion of tissue sealed and cut (109a top plan view, 109b along 9-9).
The following description is provided to enable any person skilled in the art to make and use the surgical tools and perform the methods described herein and sets forth the best modes contemplated by the inventors of carrying out their inventions. Various modifications, however, will remain apparent to those skilled in the art. It is contemplated that these modifications are within the scope of the present disclosure.
Electrosurgical System
With continued reference to
With continued reference to
With continued reference to
With continued reference to
The tissue selector 50 can comprise an electrode assembly 52 and a cutting tool 54. In various embodiments, various electrode assemblies can be configured to perform a desired electrosurgical procedure such as, for example, coagulation, cutting, or fusion, on a particular tissue. In some embodiments, the electrode assembly 52 can be configured for use as a vascular sealer. In other embodiments, the electrode assembly 52 can be configured for use as a bariatric stapler. In still other embodiments, the electrode assembly 52 can be configured for use as a tissue cutting device. In some embodiments, the cutting tool 54 can be a mechanical element such as a stationary or moveable blade or sharpened edge. In other embodiments, the cutting tool 54 can be an electrosurgical element such as an energizable wire or filament.
With continued reference to
With continued reference to
With continued reference to
With reference to
With reference to
With reference to
Integrated Electrosurgical Unit
With reference to
With reference to
With continued reference to
With continued reference to
With continued reference to
With continued reference to
With continued reference to
With reference to
With reference to
With reference to
Electrosurgical System Phase Angle Operation
Electrosurgical Unit
Generally, an electrosurgical unit is provided that includes an electrosurgical generator, an electrosurgical controller and one or more electrosurgical tool. The controller can be incorporated in or attached to the generator with the tool attached to the controller.
In one embodiment, a controller is attachable to various electrosurgical generators. The generator attached to the controller provides the supply of RF energy as directed by the controller. The controller provides feedback control and preprogrammed settings for the various attachable generators. This is largely enabled by using an internal measurement signal that is independent from the attached generator. In other words, regardless of the driving frequency of the drive signal the generator generates (which has an impact on the end point measurement, e.g., the phase shift), the measurement signal and hence the final phase shift remains the same.
Referring to
Fusing tissue in one embodiment involves applying RF current to a relatively large piece of tissue. Because of the potentially large tool contact area tissue impedance is very low. Accordingly, to deliver an effective amount of RF power, the current capability of the RF amplifier is large. As such, where a typical generator might be capable of 2 to 3 amps of current, the RF amplifier of the generator can supply more than 5 Amps RMS into low impedance loads. This results in rapid tissue fusion with minimal damage to adjacent tissue.
The RF amplifier circuitry has redundant voltage and current monitoring. One set of voltage and current sensors are connected to the PWM circuitry and are used for servo control. The voltage and current can also be read by the processor 637 using an analog to digital converter (ADC) located on the PWM circuitry. The PWM circuitry also has an analog multiplier, which calculates power by computing the product of the voltage and current. The PWM circuitry uses the average value of voltage and current and does not include a phase angle and thus is actually calculating Volt Amps Reactive (VAR) rather than actual power. A second set of voltage and current sensors are also connected to the Telemetry circuitry 642. The signals are connected to an ADC for redundant monitoring of the voltage and current. The processor multiplies the voltage and current readings to verity that power output does not exceed 400 Watts. The Telemetry circuitry has monitoring circuits that are completely independent of the PWM circuitry. This includes the ADC, which has an independent voltage reference.
The RF amplifier in one embodiment is a switching class D push pull circuitry. As such, the amplifier can generate large RF voltages into a high tissue impedance, as well as large RF currents into low tissue impedance. The output level of the RF amplifier is controlled by Pulse Width Modulation (PWM). This high voltage PWM output signal is turned into a sine wave by a low pass filter on the RF amplifier. The output of the filter is the coagulation output of the RF amplifier. The output is also stepped up in voltage by an output transformer resulting in the cut output of the RF amplifier. Only one output is connected to the control servo on the PWM circuitry at a time and only one output is selected for use at a time.
Coupled to the RF amplifier is the PWM circuitry 634. The PWM 634 in one embodiment receives voltage and current set points, which are input by the user through a user interface, to set the output level of the RF amplifier. The user sets points are translated into the operating levels by digital to analog converters of the PWM. The user sets points are translated into the operating levels by digital to analog converters of the PWM. The set points in one embodiment include a maximum voltage output, maximum current output, maximum power output, and a phase stop. The servo circuit of the PWM circuitry controls the RF output based on the three set points. The servo circuit as such controls the output voltage of the RF amplifier so that the voltage, current, and power set points are not exceeded. For example, the output of the ESG is restricted to be less than 400 watts. The individual voltage and current set point can be set to exceed 400 watts depending on the tissue impedance. The power servo however limits the power output to less than 400 watts.
The RF output voltage and current are regulated by a feedback control system. The output voltage and current are compared to set point values and the output voltage is adjusted to maintain the commanded output. The RF output is limited to 400 Watts. Two tool connections are supported by using relays 635 to multiplex the RF output and control signals. The EMI line filter 636 limits the RF leakage current by the use of an RF isolation transformer and coupling capacitors.
The cut and coagulation output voltages of the RF amplifier are connected to the relay circuitry 635. The relay circuitry in one embodiment contains a relay matrix, which steers the RF amplifiers output to one of the three output ports of the electrosurgical unit. The relay matrix also selects the configuration of the tool electrodes. The RF output is always switched off before relays are switched to prevent damage to the relay contacts. To mitigate against stuck relays steering RF to an idle output port each output port has a leakage current sensor. The sensor looks for unbalanced RF currents, such as a current leaving one tool port and returning through another tool port. The current sensors on are located on the Relay PCB, and the detectors and ADC are on the Telemetry PCB. The CPU monitors the ADC for leakage currents. Any fault detected results in an alarm condition that turns off RF power.
The relay circuitry also contains a low voltage network analyzer circuit used to measure tool impedance before RF power is turned on. The circuit measures impedance and tissue phase angle. The processor 637 uses the impedance measurement to see if the tool is short-circuited. If a Tool A or B output is shorted the system warns the user and will not turn on RF power. The RF amplifier is fully protected against short circuits. Depending on the servo settings the system can operate normally into a short circuit, and not cause a fault condition.
Voltage and current feedback is provided using isolation transformers to insure low leakage current. The control processor 637 computes the power output of the RF amplifier and compares it to the power set point, which in one embodiment is input by the user. The processor also monitors the phase lag or difference between current and voltage. Additionally, in one embodiment, the processor matches the different phase settings, which depend on tissue types to the monitored phase difference. The processor as such measures a phase shift of tissue prior to any application of RF energy. As will be described in greater detail below, the phase measurement is proportional to tissue permeability and conductivity that uniquely identifies the tissue type. Once the tissue type is identified, the phase angle associated with an end point determination of that tissue type can be determined. The generator in one embodiment has three RF output ports (Tool A, Tool B and generic bipolar). The tool A and B ports 639 are used to connect smart tools, while the generic bipolar port 640 supports standard electro surgical tools. Audible tones are produced when the RF output is active or an alarm condition exists.
The hand and foot controls are also isolated to limit leakage current. The control processor checks the inputs for valid selections before enabling the RF output. When two control inputs from the switches are simultaneously activated the RF output is turned off and an alarm is generated. Digital to analog converters are used to translate control outputs into signals useable by the Analog Servo Control. The control set points are output voltage and current. The analog to digital converter is used to process the analog phase angle measurement. Voltage RMS, current RMS, and power RMS information from the controller is also converted into a form usable for presentation to the user. The digital I/O bus interface 638 provides digital communication between the user, controller and hand/foot switches. Isolation circuitry is used to eliminate a possible leakage path from the electrosurgical generator. It also provides communication between the user and the generator though a data channel protocol.
In one embodiment, there are four tool Interface circuits in the unit. These circuits are used to electrically isolate the user input switches from mains power inside the system. The four tool interface circuits are identical and have an on board microprocessor to read the user switch inputs as well as the tool crypto memory and script memories. The switch closure resistance is measured with an ADC to eliminate a contaminated switch contact being read as a closure. Switch closures below 300 Ohms are valid, while any reading above 1000 Ohms is open. Readings between 300 and 1000 Ohms are considered to be faulty inputs.
The four tool interface circuits communicate with the processor using an RS485 network. Each tool interface circuit has jumpers to select its address and location in the unit. The RS485 interface is isolated to eliminate any potential leakage current paths. One tool interface circuit is connected to each of the Tool A and B ports. A third tool interface circuit is connected to the DC output port, and the fourth circuit is connected to the rear panel foot switch inputs. The processor is the network master and each of the four circuits is a network slave. The processor polls each circuit for input. The tool interface circuitry can only reply to commands. This makes the network deterministic and prevents any kind of dead lock. Each Tool Interface circuit is connected to a System OK logic signal. If a system error is detected by a Tool Interface circuit, this signal is asserted. The processor monitors this signal and indicates a fault. This signal also has a hardware connection to the PWM circuit and will disable the RF amplifier when asserted. A system error could be two input switches activated at the same time, or a loss of communication with the processor. The Tool A & B ports as well as the DC port have a micro switch that detects when a tool is plugged into the receptacle. Until this switch is depressed the Tool Interface circuit front panel connections are configured off to prevent any leakage current flowing from front panel connections. Once the switch is depressed the Tool Interface allows the processor to initiate reads and writes to the tool crypto memory and script memory. Once a tool is detected a window opens in the user interface display showing the type of tool connected and status. The generic bipolar port supports legacy tools, which do not have any configuration memory. The tissue measurement circuitry is used to monitor the bipolar connection contacts. When a bipolar tool is connected the tool capacitance is detected and the processor opens the bipolar tool window on the user interface display and shows status for the bipolar tool. The DC port is used to interface with 12 Volt DC powered custom surgical tools. When a tool is plugged into this port a window opens in the user interface display showing the type of tool connected and status. When the DC tool script commands power on, the processor closes a relay on the Power Control and Isolation circuitry 643 turning on the isolated 12 Volt tool power.
The power control and isolation circuitry 643 has two other features. It controls the 100 Volt power supply that drives the RF amplifier. This power supply is turned on by a relay controlled from the PWM circuitry. The processor commands this power supply on via the PWM circuitry. If the PWM circuitry is reset or detects a fault condition, the relay will not operate leaving the 100 Volt power supply off. Also located on the power control and isolation circuitry is a RS485 isolation circuit that adds an extra layer of isolation.
The front panel interface circuitry 641 is used to connect the front panel control switches and LCD display to the processor. The front panel interface circuitry also contains a microprocessor, which is powered by an isolated standby power supply, which is on whenever the main power switch is on. When the front panel power switch is pressed, the microprocessor uses a relay on the Power Control and Isolation circuitry to turn on the main logic power supply. When the button is pressed to turn power off, the microprocessor signals a power off request to the processor. When the processor is ready for power to be turned off it signals the microprocessor to turn off power. The power control relay is then opened, turning off the main power supply.
In one embodiment, the generator accepts only single switch input commands. With no RF active, e.g., RF energy applied, multiple switch closures, either from a footswitch, tool, or a combination of footswitch and tool are ignored. With RF active, dual closures shall cause an alarm and RF shall be terminated. The footswitch in one embodiment includes momentary switches providing activation of the application of RF energy. The switches for example when manipulated initiates activation of the RF energy for coagulation, for cutting and/or sequenced coagulation or cutting. A two-position pushbutton on the foot pedal switch allows toggling between different tools. The active port is indicated on the display of the generator and an LED on the hand tool.
In one embodiment, all RF activation results in a RF ON Tone. Activation tone volume is adjustable, between 40 dBA (minimum) and 65 dB (maximum) with a rear panel mounted control knob. The volume control however does not affect audio volume for alarms. Also, in one embodiment, a universal input power supply is coupled to the generator and operates over the input voltage and frequency range without the use of switches or settings. A programming port in one embodiment is used to download code to the generator and is used to upload operational data.
The generator in one embodiment provides output power has a 12V DC at 3 Amps. Examples of such tools that use DC power are, but are not limited to, a suction/irrigation pump, stapler, and a morcellator (tool for dividing into small pieces and removing, such as a tumor, etc.). The DC connector has intuitive one-way connection. Similar to the other tool receptacles, a non-sterile electronic chip module is imparted into the connector of the appropriate DC-powered hand tool by a one-time, one-way locking mechanism. Tool-specific engravings on both the connector and chip module ensure that the chip module fits only to the type of tool for which it has been programmed. The chip connector allows tool recognition and the storage of data on tool utilization. The DC connector is also configured to prevent improper insertion. The generator is also configured to recognize the attached DC-powered tool. The generator reads configuration data from the tool connector, allowing tool recognition and the storage of tool utilization data.
The controller in one embodiment recognizes the tool upon the tool being attached to the controller. Based on the recognized tool, the generator accesses and initiates specific operations and setting parameters utilized to configure the controller to properly apply RF energy as desired by the tool. For example, parameters set includes but not limited to an automatic preset of the output voltage, activation of specific output pins (connected to tool) or determination of the feedback cycle.
In one embodiment, the controller supplies control signals and/or power to a connected tool to indicate when they are active via a LED and/or a distinctive audio tone. The controller is also arranged to display when and/or which specific tool is active. The controller also prevents the tool from being reused after certain expiration of the tool shelf life, or a specific time period after the first tool activation.
In one embodiment, phase measurement is a relative measurement between two sinusoidal signals. One signal is used as a reference, and the phase shift is measured relative to that reference. Since the signals are time varying, the measurement cannot be done instantaneously. The signals must be monitored long enough so that difference between them can be determined. Typically the time difference between two know points (sine wave cross through zero) are measured to determine the phase angle. In the case of the phase controller, the device makes the output sine wave with a precise crystal controlled clock. That exact same clock is use to read the input samples with the analog to digital converter. In this way the output of the phased controller is exactly in phase with the input of the phase controller. The phase controller in one embodiment compares the input sine wave signal to a reference sine wave to determine the amount of phase shift.
The phase controller does this comparison using a mathematical process known as a Discreet Fourier Transform (DFT). In this particular case 1024 samples of the input signal are correlated point by point with both a sine function, and a cosine function. By convention the cosine part is called real, and the sine part is called imaginary. If the input signal has no phase shift the result of the DFT is 100% real. If the input signal has a 90-degree phase shift the result of the DFT is 100% imaginary. If the result of the DFT has both a real and imaginary component, the phase angle can be calculated as the arctangent of ratio of the imaginary and real values.
It should be appreciated that the phase angle calculation is independent of units of the real and imaginary numbers. Only the ratio matters. The phase results of the phase controller are also independent of gain and no calculation of impedance is made in the process of calculating the phase angle. By performing a DFT, the phase controller encodes the phase measurement as a pair of numbers.
A user interacts with the electrosurgical unit via a graphical panel display and associated switches 641. The front panel switches allow interaction with LCD display menus generated on the graphical panel display. The menus allow language selection, and modification of tool set points. In one embodiment, only when a tool is plugged in and detected by the unit, parameters can be changed for that tool.
The electrosurgical unit as described above includes one or more receptacles in which electrosurgical tools connect to the unit. Through this connection, a tool and unit communicate with each other. Connecting the tool also causes the controller to update the display of the system to show tool information and current intensity.
An example of a display or user interface 641 is shown in
In one embodiment, the user interface allows a simultaneous change to all settings for a selected tool (indicated by the highlighted rim 631) by pushing single button from the navigation buttons 632. For example, as shown in
A block diagram illustrating a controller in accordance with various aspects of the invention is shown in
The combined voltages are then applied to the tissue and, just as in the previous example, also conditioned through a buffer/level shifter circuitry for processing. Similarly, the current through the tissue is measured and also conditioned for processing. The processed voltage (and current) signal containing the high voltage (and high current) signal at 300 to 500 kHz from the ESU, as well as low voltage (low current) signal at 5 MHz are sent through a multi-pole band pass filter centering at 5 MHz. The filter discriminates the signal from the ESU, leaving only the two signals at 5 MHz for measuring the phase shift in a phase comparator. The filtered signals for both the voltage and current at 5 MHz are illustrated in
The measured phase shift is fed into a microcontroller, which compares the reading with a pre-determined level indicative to the completion of the fusion process at 5 MHz frequency. Again, when such a trigger level is achieved, i.e., the tissue fusion or welding is completed, the microcontroller 553 will cause the tissue to be discontinued from the generator and indicate that state by acoustical or visual indicator 548 (buzzer, display, lights, etc.).
In one embodiment, the phase shift is derived directly from the driving signal, i.e., the voltage and current supplied by the electrosurgical generator to the tissue. In one embodiment, an electrical circuit modifies the driving voltage having one (sinusoidal) frequency by superimposing a measurement signal at a vastly different frequency. As a result, electrical energy for the fusion process is provided at one frequency, while simultaneously applying as second signal at a second frequency for measurement. Separation of the two different signals by using band pass filters in the measurement circuit allows continuous measurement of the phase shift during the electrosurgical fusion or welding process. In one embodiment, the controller periodically interrupts the supply of electrosurgical energy to assess the status of the fusion or welding process by applying a low-voltage measurement signal. Depending on the phase shift obtained during the measurement cycle, the controller switches the driving signal from the generator back to the tissue or isolates the tissue. In one embodiment, the controller interrupts the tissue fusion or welding process at a pre-determined level of phase shift by terminating the supply of RF energy from the generator to the tissue.
The controller in one embodiment includes a processor 513 that controls the switching of the tissue between the direct output of the generator and an internal measurement circuit, e.g., switch 515. It is powered with an internal battery power module 514. The timed switching causes the tissue to be fused in intervals while periodically measuring the status of the tissue. As such, the measurement signal is a 500 kHz sinusoidal low voltage signal, generated by a signal generator 518 when fed with a 500 kHz square wave from the microprocessor 513. When the low-voltage sinusoidal measurement signal is applied to the tissue, a phase comparator 516 measures the phase shift between the applied measurement voltage and the current caused by application of the measurement voltage. Depending on the result analyzed or processed by the processor, the tissue will be either be switched back to the generator, or disconnected from the generator accompanied by an acoustical and/or visual indication via LEDs/buzzers 517.
In one embodiment, switching takes place in the following sequence. When switching from the low voltage measurement or reference signal to the generator, the first relay 528 switches out both ends of the reference and switches in one generator lead directly and one through a 100 Ohm resistor. The 100 Ohm resistor limits the surge current to two amps for a 200 Volt source. If a shorted output occurs, 400 watts are dissipated in the 3 Watt resistor, which would quickly burn up. However, approximately 50 milliseconds after the first relay 528 switches in the generator, a second relay 527 switches out the 100 Ohm resistor, keeping it from burning up and allowing the full power of the generator to be delivered to the tissue. When the device switches the other way (from the ESU to the reference signal), it first switches in the 100 Ohm resistor, reducing the current, and then switches out the generator entirely. This sequence reduces inductive kickback and EMI generation.
The relays 527,528 in one embodiment are of a latching type. Most mechanical relays draw a fair amount of power in their non-default state (an electrical current is needed to fight the force of the returning spring). Since the controller is equipped with a battery of limited power capacity, two latching type relays are used. These relays only use current to transition between two stable states and can operate at a much lower power level.
The phase detection circuitry 530 is shown in
As many generators can exclusively (but also alternatively, with the surgeons preference) be activated with a foot-pedal, the controller accommodates such a scenario. For example, if the generator is activated with a foot switch while subsequent activation of the hand switch on the tool occurs, the controller allows switching-in of the output of the generator.
The result of using the control circuit described above is shown in
In one embodiment, the fusion process starts with depressing a switch on the tool, which starts an initial measurement sequence. This point in time is marked start (switch on) 535. The tool in one embodiment checks the resistance between the two electrodes and if the phase shift is within an acceptable range. Verifying the phase shift prevents an attempt to re-fuse already fused tissue. Based on the results of the initial check, the controller switches-in the activated output of the generator to the tissue. This starts the application of RF energy to the compressed tissue. After about 850 ms, the controller disconnects the tissue from the generator and switches back to the first tissue assessment phase. Depending on the result, the tissue gets heated further, or remains disconnected from the generator to remain on the measurement circuit. The latter case is marked “power stop (switch on)” 536. In this case, an acoustical and/or visual signal is given off the unit, indicated that the tissue is sealed (or that shorting of the electrodes has occurred). The supply of the measurement signal to the tissue is ended when the switch on the tool is released, marked “manual stop (switch off)” 537. At this point, all supply of energy to the tissue is terminated.
A more detailed analysis of the measurement cycle 538 is shown in
In
Electrosurgical Systems and Processes
Electrosurgical systems and processes in various embodiments apply monopolar or bipolar high-frequency electrical energy to a patient during surgery. Such systems and processes are particularly adapted for laparoscopic and endoscopic surgeries, where spatially limited access and visibility call for simple handling, and are used to fuse blood vessels and weld other biological tissue and in one aspect to cut, dissect and separate tissue/vessels. In particular embodiments, the systems and processes include the application of RF energy to mechanically compressed tissue to (a) desiccate the tissue, and (b) to denature collagens (type I-III) and other proteins, which are abundant in most biological tissue. As heating of collagens to an appropriate temperature causes them to unfold, shrink or denature, the system enables the sealing of capillaries and blood vessels during surgery for permanent occlusion of the vessels. As described in greater detail below, as an example, arteries up to seven millimeters can be occluded and dissected by radio frequency (RF) energy and mechanical pressure.
When concurrently applying controlled high-frequency electrical energy to the compressed tissue, the tissue is compressed with a relatively high pressure (about 10-20 kg/cm2), and the tissue is supplied with sufficient electrical energy to denature proteins and remove sufficient water in the tissue. During this process, the applied voltages are sufficiently reduced to avoid electrical arcing (typically <200V RMS).
When applying electrical energy in the described manner stated above, the tissue quickly moves through the following fusion/welding process. Starting at body temperature the tissue (a) heats quickly, leading to (b) cell rupture, expelling of juices (mainly water and salt ions), (c) unraveling and “activation” of collagens and elastin in the blood vessels at about 60-650 C, and (d) desiccation of the vessel. Here, the desiccation process can be seen by the release of water in form of steam where the vessel temperature has reached about 1000 C. The reduction of water in presence of unraveled collagen and elastin strands leads to formation of bonds between collagen strands, leading to a strong and elastic seal of the tissue. As confirmed by measurements, the strongest (highest burst pressure) vessel fusions are obtained when the vessels have been heated to at least 70° C., pressurized with about 10-20 kg/cm2, and then desiccated by about 40-50% of their original water content.
Electrically, the tissue can be characterized during the fusion process by its impedance, which is typically starting at 10-100 Ohms purely ohmic resistance. During the fusion process, the purely ohmic resistance reduces by 20-50% before it increases by two orders of magnitude. As the resistance approaches a final value, the impedance of the tissue gradually increases in capacitive behavior with a phase shift of about 20 degrees. The tissue will exhibit a pronounced capacitive behavior at the end of the fusion process with a phase shift of about 40 degrees, even though the ohmic component will remain nearly unchanged during this phase.
Referring now to
The temporal progression of the applied peak voltage and peak current for the same-sized artery is provided in
Another way to depict the information from
The fusion process could be terminated (a) at a fixed and absolute resistance (for example 2k Ohms), which would neglect both the size and type of tissue, (b) at a specific multiple of the time where the ohmic resistance is minimal, (c) at a specific multiple of the time where the ohmic resistance is the same as the initial one, or (d) at a specific multiple of the time where the ohmic resistance is a certain factor of the minimal one. However, considering burst pressure of fused arteries and thermal spread, the termination of the fusion process is determined to be in the flattened part of the impedance curve. As can be seen in
Termination of the fusion process for same-material tissue (i.e., arteries) cannot be controlled with desired precision by specifying one relative ohmic load (e.g., when the resistance reaches 3 times the initial resistance). Instead, the relative change in resistance depends on the size of the vessel, i.e., <2 mm arteries seal in fractions of a second (where the resistance about doubles compared to the initial resistance), about 3 mm arteries seal in about 2 seconds (where the resistance about triples), and 15 mm arteries/veins seal in about 7 seconds (where the resistance increases by a factor of 5). At the same time, some arteries may not follow that characterization (e.g., a 3-4 mm artery would not reach more than 2.5 times the initial resistance). Instead, the fusion process should end within the flat region in
Phase Based Monitoring
In one aspect, the determination of the end-point of the fusion process is given by monitoring the phase shift of voltage and current during the fusion process. Unlike impedance, the phase shift changes much more pronounced at times where the artery desiccates and the fusion completes, and hence offers a more sensitive control value than the impedance. This can be seen when monitoring the voltage and current as function of time at different fusion times, as is shown in
In
The artery is not fully desiccated, and thus the seal is not complete. Referring to
Endpoint Determination Based on Tissue Properties
Using the phase difference between voltage and current as a control value in the fusion or welding process, instead of the impedance, can be further shown when characterizing the tissue electrically. When considering vessels and tissue to be a time-dependant ohmic resistor R and capacitor C in parallel (both of which depend on the tissue size and type) the phase difference can be obtained with
where R is the ohmic resistance, ρ the specific resistance, A the area, and d the thickness of the fused tissue,
where XC is the capacitive impedance, ω the frequency, and C the capacity of the tissue, and
where ∈ and ∈0 are the relative and absolute permittivity.
The phase difference φ can then be expressed as
As such, the difference between monitoring the phase difference φ as opposed to the (ohmic) resistance R is that φ depends on the applied frequency ω and material properties only (namely, the dielectric constant ∈ and the conductivity ρ), but not on tissue dimensions (namely the compressed tissue area A and tissue thickness d). Furthermore, the relative change in phase difference is much larger at the end of the fusion process than the change in tissue resistance, allowing for easier and more precise measurement.
In addition, with measurement of the initial dielectric properties of the tissue (dielectric constant ∈ and conductivity ρ) at a certain frequency, the type of tissue can be determined. The dielectric properties for various types of biological tissue, arranged by increasing values of the product of dielectric constant ∈ and conductivity ρ) are given in
As a result, (a) measurement of the dielectric properties of the tissue and (b) control and feedback of the phase difference allows for a precise control and feedback mechanism for various tissue types, regardless of the tissue size and allows employing standard electrosurgical power supplies (which individually run in a very close range of frequencies). It should be noted that however that specific frequency of the tissue properties measurement is performed can be the same or different from the specific frequency of the phase If the tissue measurement is based on the driving frequency of the generator, and various generators are used (all of which run in a close range of frequencies) though, the end points will be different. Hence, for such a case, it can be desirable to (1) use an external measurement signal (which is at the same frequency), or (b) utilize a stand-alone generator.
As such, the controller is configured to determine the product of dielectric constant and conductivity, as well as the phase difference between the applied voltage and current to monitor and control the tissue fusion or welding process. In particular, control and feedback circuitry of the controller determines when the phase difference reaches the phase shift value determined by the result of the dielectric and conductivity measurements. When this threshold is reached, the fusion or welding process is terminated. An indicator, e.g., visual or audible, is provided to signal the termination and in one aspect the controller restricts (completely, nearly completely or to a predetermined minimum) further delivery of electrical energy through the electrodes. As such, the tool generating the seal, weld or connection of the tissue provides atraumatic contact to the connecting tissue and provides enough burst pressure, tensile strength, or breaking strength within the tissue.
Capacitive Load Compensation of Connected Tools
In one embodiment, measuring and accounting for the tool capacitance and tool resistance is provided for consistent initial tissue assessment (conductivity and permittivity) which provides the tissue-specific endpoint of the process (i.e., coag, fuse, or weld). In another aspect of the invention, measuring and accounting for the tool capacitance and tool resistance is provided for consistent tissue feedback measurements (phase shift) which ensures consistent tissue modification results (i.e., coag, fuse or weld).
The values of the ohmic and capacitive impedances found in typical arrangements of tools are in the range of 1-10 Ohms for the ohmic load and 1-100 kOhms for capacitive resistances (several ten to several hundred pF capacitance at several 100 kHz). Even for two equal tools variations in the tool characteristics (such as wire connections, harness length, etc.) can lead to different phase angles □ and □′ for the same tool. As will be shown in the following, these variations can lead to different tissue measurement results, used both before and during tissue assessment.
As shown in
In this context, the presence of the tool (impedance) does not pose an actual problem if the tissue measurement before powering (to determine end point of fuse/weld), or during powering (to determine the end point of the fuse/weld) has been defined with the very same tool (i.e., tool impedance). Instead, variances of the tool impedances lead to different results in both the initial tissue assessment (pointing to an inaccurate endpoint) and tissue feedback measurement (determining the end point of the fuse/weld).
As such, the controller used to measure the phase shift during the tissue modification process can be used to initially determine the initial tool impedance (e.g., during plug-in of the tool connector to the electrosurgical generator), where tolerances/changes in the tool characteristics are then accounted for in the tissue measurement algorithm. This will allow for tissue measurement values which are independent of the ohmic and capacitive values and/or tolerances of the specific electrosurgical tool.
Accordingly, generally speaking, when tool capacitance increases, the endpoint phase shift decreases. In particular, when the tool capacitance increases, the capacitive impedance decreases (X=1/ωC). Decreased capacitive impedance leads to a smaller or decreased end point phase shift. Similarly, when tool resistance increases, the end point phase shift decreases.
Also, from an initial tissue determination perspective, generally speaking, when tool capacitance increases, the apparent initial phase shift decreases compared to the “ideal” value. The “ideal” value being a tool having zero or near zero capacitance. Similarly, when tool resistance increases, the apparent initial phase shift decreases compared to the “ideal” value. As such, when the tool capacitance (C=∈∈0A/d) and/or the tool resistance (R=ρd/A) increase, there is an increase in permittivity and/or conductivity which reflects a decrease in tan φ, i.e., a decrease in phase. In one example, an electrosurgical tool having a capacitance of 160 pF had an initial phase shift of 9-59 degrees versus a tool having a capacitance of 230 pF having an initial phase shift of 6-23 degrees. Additionally with tissue permittivity and conductivity product values being inversely proportional with the initial phase shift, when tool capacitance and/or resistance increases, the apparent tissue permittivity and conductivity product value increases compared to the “ideal” value.
Instead of the tissue quickly reaching a pre-determined phase (ranging from 40 to 60 degrees, depending on type of tissue), the measured phase shift approaches the cut-off threshold asymptotically. This is shown in
Additionally, the determined phase value can be overshot without being detected, for example, when the phase trip level is reached during the read out time of the processor controlling the power supply. In such cases, the processor may not recognize that the final phase stop has been reached. This is shown in
The derivative of the phase value of the same seal is shown in
As previously described and described throughout the application, the electrosurgical generator ultimately supplies RF energy to a connected electrosurgical tool. The electrosurgical generator ensures that the supplied RF energy does not exceed specified parameters and detects faults or error conditions. In various embodiments, however, an electrosurgical tool provides the commands or logic used to appropriately apply RF energy for a surgical procedure. An electrosurgical tool includes memory having commands and parameters that dictate the operation of the tool in conjunction with the electrosurgical generator. For example, in a simple case, the generator can supply the RF energy but the connected tool decides how much energy is applied. The generator however does not allow the supply of RF energy to exceed a set threshold even if directed to by the connected tool thereby providing a check or assurance against a faulty tool command.
In one embodiment, each tool comes with an integrated circuit that provides tool authentication, configuration, expiration, and logging. Connection of tools into the receptacles or ports initiates a tool verification and identification process. Tool authentication in one embodiment is provided via a challenge-response scheme and/or a stored secret key also shared by the controller. Other parameters have hash keys for integrity checks. Usages are logged to the controller and/or to the tool integrated circuit. Errors in one embodiment can result in unlogged usage. In one embodiment, the log record is set in binary and interpreted with offline tools or via the controller.
In one embodiment, connection of a standard bipolar tool into the standard bipolar outlet will not actively check the tool. However, the controller recognizes a connection so that the information on the bipolar outlet can be displayed on the monitor or user interface of the unit. The display reserves a field for the bipolar outlet before the outlet is activated. In one embodiment, the controller uses time measurement components to monitor a tool's expiration. Such components utilize polling oscillators or timers, real-time calendar clocks and are configured at boot time. Timer interrupts are handled by the controller and can be used by scripts for timeouts. Logging also utilizes timers or counters to timestamp logged events.
The tool in one embodiment has memory integrated with or removable from the tool. A tool algorithm or script within the tool's memory is loaded into a script interpreter of the generator. The script provides commands and parameters readying the tool for use when connected to the generator. Upon activation of a switch coupled to the tool, the controller detects the switch closure, and authenticates the tool, checks the tool's expiration status, and initializes internal data structures representing the receptacle's tool. A subsequent activation of the tool switch initiates an event that causes the script to direct the generator to supply RF energy. The controller logs the usage to both the tool and the generator. When the tool is disconnected from the receptacle of the generator, the controller resets the information associated with the receptacle. The controller constantly monitors the generator for proper operation. Unrecoverable errors and faults are announced and further operation of the system is prevented. All faults are stored in the controller's memory and/or the tool's memory.
Data from a specific procedure (e.g., from power-up to power-down) is stored on each tool. The tool additionally holds the data from a procedure, i.e., the number of tool uses, the power setting and faults. Each tool in one embodiment holds the information from all other tools as well. Tool memory includes but is not limited to the following parameters: serial number of generator, time stamp, tissue assessment and endpoint setting for each tool use, cut, coagulation, weld, power setting, duration of RF and endpoint (auto stop, fault, manual stop, etc.).
The generator logs usage details in an internal log that is down loadable. The generator has memory for storage of code and machine performance. The generator has reprogrammable memory that contains instructions for specific tool performance. The memory for example retains a serial number and tool use parameters. The generator stores information on the type of tools connected. Such information includes but is not limited to a tool identifier, e.g., a serial number of a connected tool, along with a time stamp, number of uses or duration of use of the connected tool, power setting of each and changes made to the default setting. The memory in one embodiment holds data for about two months or about 10,000 tool uses and is configured to overwrite itself as needed.
In one embodiment, the controller includes a state machine interpreter module that parses tool scripts. Tool scripts represent a tool process for a specific or given tool. The tool scripts are stored on memory connected to or integrated with a tool, the controller or a combination thereof. The state machine interpreter module responds to specific events, such as a switch activation/de-activation, tool positions or exceeding measurement thresholds. The module upon response controls the output of RF energy and/or electrode activation. In one embodiment, an interpreter module is provided for each tool input receptacle. The controller detects tool events and forwards the detected event to the appropriate interpreter module. The module in turn requests actions of the controller based on the detected event which provides output to the connected tool associated with the appropriate tool input receptacle and also the appropriate interpreter module.
In one embodiment, the controller has a specific or predetermined fixed tool script for a specific input receptacle. As such, only this tool script is used for the tool connected to the particular input receptacle. The interpreter module includes an event detector and a script parser. The event detector receives and identifies tool events, such as a switch activation/de-activation event or a measurement event (e.g., phase threshold exceeded). The event detector formulates requests to the controller to control RF output, output selection and/or selection of outputs, changes to the display and audio tones. Other events detected include detecting hand and foot switches, jaw switches, phase over and phase under-after-over events, shorts and opens, tool script states. The script parser interprets the tool scripts. Keywords in the scripts assist the script parser to extract operational commands and data for tool operation based on a detected event identified by the event detector. In addition to the voltage, current, etc. set points, a tool script specifies the RF source as from the CUT or the COAG source. The script also specifies which electrodes get connected to RF+, RF−, or allowed to float. Because the script controls the electrode configuration, and can set thresholds that trigger events, a script can completely reconfigure tool during its use.
The script controls the voltage and current output settings as well as sequences of voltage and current settings. For example the permittivity and conductivity of blood vessels is the same independent of size. A small blood vessel will fuse very rapidly while a large vessel may take several seconds. Applying a large amount of current to a small vessel may cause excess tissue damage, while using a small amount of current will take an unacceptably long time to perform the fusion function. So to modify tool performance the script can initially command a small amount of RF current, and if fusion endpoint is not reached in less than one second, a high current is commanded to speed the fusion of a large vessel. Another script usage to modify tool performance to switch from one operation (coagulation) to another operation (cut) is to reconfigure the tool electrodes and ESG output to simplify a multistep process such as fuse and cut. When the clinician starts the process the script will first setup the unit for the fusion, measure the tissue phase angle that indicates the fusion endpoint. RF power is then turned on until the fusion endpoint is reached. The unit will then turn off RF power and beep to indicate that fusion is complete. The unit then switches the electrodes to the cut configuration, sets the RF output for cut, and restarts the RF output. The cut operation is stopped by the clinician when the cut is completed.
Referring to
Based on the tool algorithm for the connected tool, the tool verification and determination of an end point can vary. In particular, a tool short is determined by measuring resistance at a tissue contacting surface of the tool. If the resistance is less than ten (10) Ohms, a tool short condition is recognized. In accordance with various embodiments, the product of measured tissue permittivity and conductivity or an initial phase shift is utilized to determine the end point for a connected tool.
In accordance with various embodiments, phase shift and/or a phase rate of change is measured throughout the process to determine if an endpoint is reached or exceeded. Also, timeout parameters, e.g., a timer or counter reaching or exceeding a set time limit, or a fault condition stops or interrupts the process even if the determined end point is not reached or exceeded.
Handheld Electrosurgical Tools
As described generally above and described in further detail below, various handheld electrosurgical tools can be used in the electrosurgical systems described herein. For example, electrosurgical graspers, scissors, tweezers, probes, needles, and other instruments incorporating one, some, or all of the aspects discussed herein can provide various advantages in an electrosurgical system. Various embodiments electrosurgical tool are discussed below. It is contemplated that one, some, or all of the features discussed generally below can be included in any of the embodiment of tool discussed below. For example, it can be desirable that each of the tools described below include a memory for interaction with a feedback circuit as described above. However, in other embodiments, the tools described below can be configured to interact with a standard bipolar power source without interaction of a tool memory. Furthermore, although it is contemplated that certain aspects of these embodiments can be combined with certain aspects of other electrosurgical tools within the scope of this application. Certain aspects of these electrosurgical tools are discussed generally herein, and in more detail with respect to various embodiments below.
As discussed above with respect to
The configuration device module can further store a data log comprising, for example, a record of information of each previous tool use. For example, in some embodiments, the data log can contain timestamp data including an electrosurgical unit identifier, a log of electrosurgical procedures perform by the tool, and a log of durations and energies applied to the tool. In some embodiments, it can be desirable that use of a particular tool is limited to a maximum usage period or number of procedures, especially where electrosurgical tool has not been configured for sterilization and reuse. Accordingly, in some embodiments, the configuration device module can be configured to prevent operation of a tool after a predetermined usage or number of procedures. In some embodiments, a tool can comprise a mechanical lockout in addition to or in place of the data log, such as a breakaway single-use connector to reduce the possibility of unintended reuse.
In some embodiments, it is desirable that the tool communicate with the electrosurgical unit through an encrypted protocol. Accordingly, the memory can further store an encryption module, or encryption key to facilitate this encrypted communication.
As discussed above with respect to
Electrosurgical Fusion Tool
With reference to
With reference to
With continued reference to
With continued reference to
In the illustrated embodiment, the force regulation mechanism 1200 includes a biasing member such as a trigger spring 1208 that biases the pin in a proximal direction towards the rear of the pin slots in the right and left handle frames (see, for example,
While the illustrated embodiment includes a pin-in-slot arrangement coupling one pivot point of the actuation handle to the stationary handle, in other embodiments, it is contemplated that other connections can be formed. For example, in some embodiments, a slot can be formed in the actuation handle and a mating projection can be formed in the stationary handle. Furthermore, while the illustrated embodiment includes a tension coil spring forming the biasing member, in other embodiments, other biasing members are contemplated. For example, the biasing member can comprise a compression spring, a torsion spring, an elastomeric band, a fluid-filled shock absorbing unit, or another suitable biasing device.
With continued reference to
As illustrated, the pull block 1250 comprises a generally rectangular prismatic structure having a generally open top and bottom faces and a substantially closed proximal end. The actuation handle 1114 can extend through the top and bottom faces of the pull block 1250. An edge of the actuation handle 1114 can bear on the proximal end of the pull block 1250 such that movement of the actuation handle 1114 relative to the stationary handle can move the pull block 1250 generally longitudinally along the actuation path defined by the rails. A distal end of the pull block 1250 can be coupled with an actuation shaft such as an actuation tube, bar, or rod, which can extend longitudinally along the elongate shaft of the sealer/divider. Thus, in operation, movement of the actuation handle 1114 from the first position to the second position translates the pull block 1250 longitudinally within the stationary housing, which correspondingly translates the actuation rod generally linearly along the longitudinal axis with respect to the elongate shaft. Movement of this actuation tube can control relative movement of the jaws in the jaw assembly.
With continued reference to
In some embodiments, the jaw assembly 1130 of the sealer/divider comprises an advanceable cutting blade 1400 (
With reference to
In certain embodiments of sealer/divider, inside the actuation handle 1112, two of the leads are attached to rotational coupling clips 1502 configured to allow infinite rotation of the jaw assembly 1130, as discussed in greater detail below, two of the other leads are attached to a visible indicator 1504, such as a multi-colored LED, and the remaining two leads are attached to a switch 1506. In some embodiments, the switch 1506 is connected to a user manipulated activation button and is activated when the activation button is depressed. In one aspect, once activated, the switch 1506 completes a circuit by electrically coupling the two leads together. As such, an electrical path is then established from an electrosurgical generator to the actuator to supply radio frequency power to one of the two leads attached to the rotational coupling clips 1502.
Referring now to
With continued reference to
Desirably, the rotational shaft assembly 1600 provides the vessel sealer/divider with continuous 360 degree rotation throughout operation of the electrosurgical instrument. By using rotational coupling clips 1502 for the electrical connections to the shaft, the shaft can operate, e.g., deliver RF energy, at any orientation or rotation of the jaw assembly 1130 relative to the handle assembly. Thus, advantageously, the surgeon is provided more surgical options for the placement and activation of the sealer/divider. Advantageously, with a rotational shaft assembly 1600, the wires and electrical and mechanical connections, as such, do not interfere with continuous, infinite rotation of the shaft. To maintain a bipolar connection through the rotational shaft assembly 1600, one of the electrical connections is electrically isolated from other conductive portions of the shaft.
As discussed in further detail below, in some embodiments, the sealer/divider can be configured to grasp with a gripping force within a predetermined range. In one embodiment, an overall tolerance stack-up over the length of the shaft can be controlled so that the force applied to the jaw assembly 1130 from the handle assembly can be maintained accurately within the predetermined range. The overall length of the shaft 1120 can be controlled by using threaded nuts 1604 and a threaded coupling. The threaded nuts 1604 can be adjusted to tightly control the length of the elongate shaft 1120. The length is controlled by maintaining the location of the threaded nuts 1604 in relation to the hub portions of the shaft. In the illustrated embodiment, attached to the distal end of the actuation tube is a threaded coupling. Attached to the threaded coupling are two threaded nuts, which are configured to engage with the pull block 1250. The pull block 1250 engages with the threaded nuts 1604 which are attached to the rear of the actuation tube, causing the actuation tube to move proximally. The described interaction can also be reversed so that the threaded nuts 1604 and coupling are attached to an outer cover tube rather than the actuation tube. In other embodiments, other length adjustment mechanisms can be used to control the overall tolerance stack-up such as a lock screw to selectively secure the position of the pull block 1250 at a desired location relative to the actuation tube or toothed ratchet interfaces defining set distance relationships between the pull bock and the actuation tube. In other embodiments, a length adjustment mechanism can be positioned at the distal end of the elongate shaft, e.g., where the elongate shaft interfaces with the jaw assembly 1130.
Referring to
As discussed above with respect to length adjustment of the elongate shaft 1120, in the illustrated embodiment attached to the distal end of the actuation tube 1122 is a threaded coupling 1150 (
With continued reference to
With reference to
In some embodiments, one jaw can be fixed with respect to the elongate shaft 1120 such that the opposing jaw pivots with respect to the fixed jaw between an open and a closed position. For example, in the illustrated embodiment, the proximal portion of the lower jaw 1134 extends inside the cover tube 1126 and is crimped in place, fixing the jaw assembly 1130 to the rotation shaft assembly 1600. Thus, in the illustrated embodiment, the upper jaw 1132 is moveable with respect to a fixed lower jaw 1134. In other embodiments, both jaws can be pivotally coupled to the elongate shaft such that both jaws can pivot with respect to each other.
Attached to the upper jaw 1132 is the upper conductive assembly 1142, which comprises a nonconductive portion 1702 and a conductive pad 1704 (see
The jaw assembly 1130 can include one or more nonconductive space maintaining members such as spacers 1144 to reduce the risk that electrodes on the upper jaw 1132 and lower jaw 1134 can come into direct contact and create a short. In the illustrated embodiment, the lower nonconductive spacer 1144 is housed inside the u-groove portion of the lower jaw and contains space maintaining protrusions which prevent the conductive pad from contacting the lower jaw (see
Turning now to some of the operational aspects of the electrosurgical instruments described herein, once a vessel 1030 or tissue bundle has been identified for sealing, the upper and lower jaws are placed around the tissue (see
The continued manipulation of the actuation handle 1114 pivots the actuation handle 1114 to a location where the actuation handle 1114 engages with the latch mechanism 1260 in the right and left handle frames that maintains the trigger in the engaged position and prevents the trigger from returning to an opened position. When the engaged position is reached and nothing is present between the upper and lower jaws 1132, 1134, the trigger spring is extended to a distance that ensures that the force applied to the electrodes of the jaw assembly 1130 is near the lower end of the force range required for optimal vessel sealing. When a large, e.g., maximum, amount of tissue is placed in the jaws, the actuation handle 1114 extends the trigger spring 1208 a greater distance. However, the trigger spring 1208 ensures that the maximum amount of force applied does not exceed the maximum end of the force range used for optimal vessel sealing. From the engaged position, sealing radio frequency energy is applied to the tissue by depressing the power activation button. Once the tissue has been sealed, the actuation trigger can be reopened by continuing proximal advancement to a position that allows the actuation trigger's finger portion to disengage from the latch portions of the left and right handle frames. (See
The floating dual pivoting mechanism including a sliding pin 1206 and a pull block 1250 described above desirably provides a minimum force, optimal for sealing vessels and tissue, is maintained regardless of the amount of substance contained between the upper and lower jaws. This mechanism also reduces the risk that an extremely large amount of force is applied to the tissue. If too much force is applied to a vessel or tissue bundle, potential damage could occur. Thus, if a very small vessel or thin tissue bundle is clamped within the jaw, the instrument applies the minimum amount of force required to obtain a good tissue weld. The same is true with a very large vessel or tissue bundle. Since the travel of the jaw can vary greatly depending on tissue thickness, the force applied by the jaw is adjustable. It is desired that the instrument be self-adjusting and automatic (no action from the user). The floating dual pivot mechanism described below provides the self-adjustment, applying a specific range of force along the length of the electrode.
Once the actuation handle 1114 has been depressed to a predetermined force range for optimal vessel sealing, it will engage the matching latch of the right and left handle frames, locking the actuation trigger from moving further distally (See
Once the tissue has been sealed, the user can actuate the blade trigger 1402. When the blade trigger 1402 is moved proximally, the blade lever pivots, forcing the front and rear blade shafts and cutting blade 1400 to move distally. The cutting blade advances forward and divides the sealed portion of the tissue (see
The electrosurgical instrument is connectable to an electrosurgical generator specifically configured to apply the proper amount of energy to the tissue when the activation button is depressed, such as the electrosurgical generator described above. With reference to
With continued reference to
In grasping jaw assemblies such as the jaw assembly 1130 of the electrosurgical tool, the gripping force generated between the jaws can vary along the length of the jaws from a relative maximum Fmax near the proximal end to a relative minimum Fmin near the distal end. In some embodiments, the electrosurgical tool can be configured such that the forces are optimized along the length of the active electrode portions of the jaws, a predetermined force range for vessel sealing is maintained. A predetermined maximum amount of force utilized to obtain a proper vessel seal is desirably not exceeded at the proximal end of the active electrodes (closest to the pivot). In addition a gripping force at the distal most ends of the active electrodes is desirably greater than a predetermined minimum amount of force for optimal vessel sealing. Desirably, the gripping force generated at every point along the jaw assembly 1130 is within the range defined by the predetermined maximum force and the predetermined minimum force to achieve optimal sealing. (See
In some embodiments, the electrode width to form vessel seals is between about 0.25 mm and about 1.5 mm. In other embodiments, the electrode width is desirably between about 0.4 mm and about 1 mm. In other embodiments, the electrode width is preferably between about 0.6 mm and 0.8 mm. In some embodiments, the electrode width is approximately 0.75 mm. With an electrode of 0.75 mm, and the sufficient pressure for this type of electrode to achieve a vessel seal is approximately 3 pounds (see
In some embodiments, electrode geometry on the conductive pads of the jaw assembly 1130 ensures that the sealing area completely encloses the distal portion of the blade cutting path. Single linear electrodes could cause vessel leakage when only a portion of a vessel is sealed. In one embodiment, the electrodes positioned on the jaw assembly 1130 comprise a single unshaped electrode 1902 surface on each of the upper and lower jaws. Each u-shaped electrode can comprise generally parallel linear legs 1910 extending from a proximal end of the conductive pad of the jaw towards the distal end and a curved connector 1912 at the distal end extending from one leg to the opposite leg. Desirably, the u-shaped electrodes can completely encompass the distal end of the blade cutting path. In other embodiments, to provide a greater sealing area, two or more spaced u-shaped electrode surfaces on both the upper and lower jaws can be provided (see
In some embodiments, for some surgical procedures the outer shape of the jaws 1130′ can be curved such that the distal ends of the jaws are offset with respect to the longitudinal axis from the proximal ends of the jaws to improve visibility for a user such as a surgeon. In embodiments with curved jaws, the u-shaped electrodes can also be provided in a curved fashion while still maintaining proper electrode width and spacing (see
With reference to
With continued reference to
With reference to
With reference to
With reference to
The vessel sealer/divider can use thin metallic tubes and small diameter machined rods for the internal elongated components used to actuate jaws such as the actuation tube and the blade actuation shaft. However, such components can be costly and in some embodiments, manufacturing and materials costs can be desirably reduced through the use of elongate injection molded plastic components. As discussed above with respect to the blade actuation shaft 1124, in some embodiments, costs and manufacturing difficulties can be reduced further through the use of an elongated shaft formed of two mating polymer shaft sections 124a, 1124b such as a proximal or rear shaft portion and a distal or front shaft portion. In some embodiments, the two shaft portions 1124a, 1124b can be connected by interlocks 1960, e.g., projections on one shaft section or component mating with corresponding slots on the other shaft section, to maintain concentricity and prevent unnecessary movement in their axial direction (see
With reference to
As discussed above with respect to the electrosurgical system, in certain embodiments the electrosurgical tool can comprise a memory such as a tool ID chip mounted on a small PCB. In some embodiments, the PCB can be disposed on or in the actuation handle 1112. In other embodiments, the PCB and chip can be integrated in the plug of the wiring harness. The PCB and chip can be molded with a tool-specific pattern. The tool ID chip and PCB can be electrically connected into the wiring harness and plug of the electrosurgical tool. A “spacer” between the plug and the tool ID chip, can allow the use of the same connector for all tools. In some embodiments, the spacer can have the same shape for all tools on the plug side, and a tool-specific pattern on the chip side such that during assembly there is a reduced risk that a PCB for one type of electrosurgical tool can be assembled into a different type of electrosurgical tool.
As discussed above with respect to the electrosurgical system, when the plug is inserted into the generator, the encrypted tool information stored in the memory is verified. General information (serial number of tool and generator) are exchanged, and the tool-specific software is uploaded into the generator. With completion of each tool use, tool-specific information (connections to generator, individual tool uses, errors, etc.) can be communicated, if needed, and stored in memory of the generator, the tool chip or both. In exemplary embodiment, the generator's memory is sized to hold data for about two months while the tool chip's memory can hold data for one surgical procedure.
As discussed above with respect to the electrosurgical system, in some embodiments, the electrosurgical fusion tool can be used in a system which monitors various operational parameters and determines a radiofrequency endpoint based on phase angle.
Although the present invention has been described in certain specific aspects, many additional modifications and variations would be apparent to those skilled in the art. It is therefore to be understood that the present invention may be practiced otherwise than specifically described, including various changes in the size, shape and materials, without departing from the scope and spirit of the present invention. Thus, embodiments of the present invention should be considered in all respects as illustrative and not restrictive.
Electrosurgical Dissection Tool
Laparoscopic surgical procedures typically require the dissection of connective or vascular tissue. Depending on factors such as tissue type, size, location and condition of the specific tissue, different tools and techniques can be used to perform a specific procedure. The choice of an individual tool can be based on functionality combined with a desire that the selected tool provide relatively little traumatic damage to the surrounding tissue. As an example, the dissection of connective tissue is usually performed by mechanical or electrosurgical cutting, whereas the dissection of vascular tissue typically relies on ligating techniques employing clips or staplers followed by a mechanical cut. Consequently, a typical laparoscopic procedure including dissection of both connective tissue and vascular tissue calls for multiple tools being consecutively exchanged through trocar access ports to the surgical site. This tool exchange increases both the cost and time of the surgical procedure. It is hence desirable to provide multi-functional tools that can greatly reduce the number of tool exchanges during laparoscopic procedures.
Referring now to
With continued reference to
With reference to
As schematically depicted in
In contrast to the prior art electrosurgical devices, with reference to
With the electrode arrangement illustrated in
With continued reference to
With continued reference to
With continued reference to
Another embodiment of electrode arrangement for a surgical tool is illustrated in
With continued reference to
With continued reference to
Another embodiment of electrode arrangement for a surgical tool is illustrated in
The separation of cutting electrodes 2304 and 309 facilitates cutting of tissue that is positioned within the upper and lower jaw elements (not fully opened), or cutting of tissue in contact with the bottom side of the tool. The separation prevents inadvertent cutting of tissue.
Another embodiment of electrode arrangement for a surgical tool is illustrated in
With continued reference to
With continued reference to
With continued reference to
The practicality of the tool configurations of
a illustrates a schematic circuit diagram for an electrode arrangement as given in
b illustrates a schematic power supply circuit that can be used for the electrode arrangement shown in
c illustrates a schematic power supply circuit that can be used to address the electrode arrangement of
As discussed in more detail above, the activation (or deactivation) of specific electrodes can configure the tool in a coagulation state or a cutting state. In certain embodiments, the selective activation and deactivation of specific electrodes can be facilitated by push-buttons, switches, or other electrical switching devices mounted on the hand-piece of the laparoscopic tool, or wired or wireless switches. In other embodiments, the selective activation and deactivation of specific electrodes can be facilitated by switches or other electrical switching devices that are incorporated into the handle mechanism of the hand-piece to switch at various positions of the jaw elements.
Regarding the circuit shown in
One benefit of switching the electrodes from a coagulation state to a cutting state at different positions of the jaw elements (e.g., open and nearly closed jaws) can be seen with respect to the embodiment of
In the described embodiment, the electrode switches are automatically actuated as the jaw elements are closed. Although the described embodiment includes a switch point between a coagulation state and a cutting state upon commencement of closure from the jaws fully opened position, other embodiments can have different switching positions. For example, with this automatic switching, the switches 2403, 2404 can be configured such that the electrodes are activated and deactivated at any position in an opening or closing cycle. In other embodiments, a surgical tool can include the electrode configuration of
Similarly, in certain embodiments, a surgical tool having the electrode configuration of
With reference to
With continued reference to
With reference to
One contact strip and pin arrangement is illustrated in
While both
Similarly,
With reference to
In the tissue assessment step 2954, a measurement signal is applied to the tissue by the coagulation electrodes to determine a future trigger level to switch from coagulation to cutting. This determination can be achieved by measuring the product of conductivity and permittivity of the tissue, pointing to the desired electrical phase shift switching level for the respective tissue. For example, in some embodiments, desirable cutting switching levels occur at 10 degrees to 40 degrees. More desirably, the preferred switching level for blood vessels is between 10 to 30 degrees phase shift, while for highly vascular tissue (such as organs) it is rather between 20 to 40 degrees.
In the applying-electrical-energy-to-coagulate step 2956, electrical energy is applied to the electrosurgical tool in a coagulation configuration to achieve hemostasis in the tissue. In various embodiments discussed herein, electrode configurations for coagulation are provided. For example, applying electrical energy to the electrosurgical tool in the coagulation configuration can comprise supplying one of a plurality of electrodes with electrical energy having a first polarity and supplying another of the plurality of electrodes with electrical energy having a second polarity generally opposite the first polarity. Desirably, a potential difference between the electrode having the first polarity and the electrode having the second polarity is no more than approximately 200 V.
During the coagulation process of the tissue the phase shift between applied voltage and incurred current is measured concurrently in step 2958 to provide feedback of the coagulation status. Once the pre-determined switching level is reached, the process will proceed to the switching step 2960.
In the switching step 2960, as discussed above, some embodiments of electrosurgical tool can comprise a handle assembly including a switching mechanism. This switching mechanism can selectively configure the electrosurgical tool in either the coagulation configuration or the cutting configuration depending on a position of a trigger of the handle assembly. As discussed above, in some embodiments the switching mechanism can be configured such that with the electrosurgical tool in an open position, the electrodes are configured in the coagulation configuration. The switching mechanism can further be configured such that when the electrosurgical tool is moved towards a closed position, the electrodes are configured in the cutting configuration. In other embodiments, switching of the configuration of electrodes from the coagulation configuration to the cutting configuration can occur at different predetermined positions of the trigger of the handle assembly. In yet another embodiment, the switching can occur within a multi-electrode power supply as shown in
In the applying-electrical-energy-to-cut step 2962, electrical energy is applied to the electrosurgical tool in a cutting configuration to dissect the tissue. In various embodiments discussed herein, electrode configurations for cutting are provided. For example, applying electrical energy to the electrosurgical tool in the cutting configuration can comprise supplying one of a plurality of electrodes with electrical energy and configuring another of the plurality of electrodes as a return electrode. Desirably, a potential difference between the cutting electrode and the return electrode is between approximately 300 V and approximately 500 V.
Electrosurgical Tissue Stapler
Historically, connecting or reconnecting living tissue has involved the use of suture, clips or staples. More recently, the use of electricity or heat has come to be used to complete the connection of living tissue or seal connected tissue against leakage or bleeding.
However, there remains a need to secure or connect portions of living tissue, especially conduits, without the use of staples, suture or clips.
An apparatus and method for permanently attaching or connecting living tissue comprising an electro-surgically generated electrical current that is delivered to tissue by a clamping jaw having features that increase current density at preferred locations are provided.
Referring to
With reference to
With continued reference to
With reference to
With continued reference to
With continued reference to
With reference also to
With continued reference to
With reference to
As discussed further below, in some embodiments, the contact strips 3390, 3391, 3392, 3393 can be electrically energized such that the electrosurgical tool operates as a bipolar surgical tool. In the illustrated embodiment, which includes four longitudinally extending columns of electrodes 3320 (see, e.g.,
With reference to
In operation, as the sled 3380 is advanced distally, the contacting surfaces 3323, 3322 of the electrodes 3320 and the cam surfaces 389 of the contactor peaks 3385 engage and extend the individual pairs of electrodes 3320 beyond the contacting face 3281 of the first jaw 3280. As the sled 3380 is advanced distally past a pair of electrodes 3320, the pair retracts into the first jaw 3280. Desirably, the electrodes 3320 are configured to be maintained within the jaw assembly after extension of the electrodes rather than be deposited in tissue once the electrosurgical tool is removed from a tissue site. As illustrated, the electrode pairs 3320 do not extend completely out of the first jaw 3280 as a contact surface 330 on the upper surface of the flattened structural portion 3321 interferes with the contacting face 3281 of the first jaw. While the illustrated embodiment illustrates paired electrodes 3320 with a connecting flattened structural portion 3321, in other embodiments, single electrodes 3320 can be maintained within the first jaw by a flared lower portion or flanged extensions that interfere with the contacting face 3281 of the first jaw.
With reference to
With reference to
Referring now to
With reference to
With reference to
A section view of the activity associated with the electrodes 3325 may be seen in
Electro-surgery involves managing the timing and temperature of the procedure. Too little generated heat within the tissue prevents the tissue from properly fusing or welding and too much heat within the tissue may destroy it and result in complications. As such, the electrosurgical tool can be less sensitive to the variables within living tissue. The instrument may be coupled to feedback systems that measure or respond to conditions that develop within treated tissue. For instance, the electrosurgical tool may desiccate tissue during the heating phase so that resistance to electrical current develops. In some embodiments, that resistance may be measured or otherwise used to control the delivery of electrosurgical energy to the electrodes. In some embodiments, the phase changes between the initiation of the electrosurgical energy and any subsequent point during the delivery of the electrosurgical energy may be used to control the delivery. In other embodiments, a measurement of the temperature of the treated tissue can also be used to control the delivery.
A comparison between various methods of conduit occlusion may be appreciated in
With reference to
As is apparent from the above discussion and
With reference to
With reference to
Referring to
While in illustrated embodiments, the cutting element is illustrated as a mechanical element, in other embodiments, the cutting element 3371 can comprise an energizable element or wire that can be selectively energized by a generator or power source. An electrosurgical cutting element 3371 can easily separate the compressed and fused tissue portion and can additionally provide fluid stasis or additional sealing of the lumen 3032 associated with the treated tissue 3030.
In some embodiments, the elements can comprise holes 3500 that function as energy horns, as shown in
With reference to
a illustrates an exemplary sealed and cut tissue segment 3030, obtained by welding the tissue in two double-rows of round areas, and cutting the tissue between the two double rows. The divided portions of the tissue are each sealed in a fluid tight manner by the respective double-rows of fused circles. The tissue between the fused circles, on the other hand, does not have to be fused, or even connected. This is shown, for example, in
With reference to
Referring to
It is believed that UV (200 to 400 nanometers) is absorbed by proteins (and hemoglobin), leading to cleavage of chemical bonds within the proteins, while IR (>1 micrometer) is strongly absorbed by water, causing heating of the tissue. It has been demonstrated that the fusion of clamped arteries using incoherent UV within the spectral range of 300 to 500 nanometers, without substantial heating of the artery can be accomplished. The irradiation of the pressurized tissue with UV can cause collagens to bind each other through photochemical reactions, without desiccation or thermally-induced collagen degeneration.
In one aspect, the tissue is fused or welded in a manner that emulates the placement of a plurality of staples. The portions of tissue that have been treated resemble a connection made by staples. However, using the electrosurgical tool, a single grasping procedure can simulate the release of tens of staples, thus resulting in significant time savings over a similar procedure with a surgical stapler. When compared with a surgical stapler, advantageously, the second, closing jaw of the electrosurgical tool does not need to be of sufficient strength to provide an anvil for the folding or bending of staple legs. It may therefore favor laparoscopic applications where the device may have to be operated through a small tubular access port.
Although this application discloses certain preferred embodiments and examples, it will be understood by those skilled in the art that the present inventions extend beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the invention and obvious modifications and equivalents thereof. Further, the various features of these inventions can be used alone, or in combination with other features of these inventions other than as expressly described above. Thus, it is intended that the scope of the present inventions herein disclosed should not be limited by the particular disclosed embodiments described above, but should be determined only by a fair reading of the following claims.
This application is a continuation of U.S. patent application Ser. No. 12/416,128, entitled “ELECTROSURGICAL SYSTEM”, filed Mar. 31, 2009, currently pending, which claims the benefit of U.S. Provisional Patent Application Ser. No. 61/040,980, entitled “FEEDBACK CONTROL MECHANISM FOR FUSING BIOLOGICAL TISSUE WITH HIGH FREQUENCY ELECTRICAL ENERGY”, filed Mar. 31, 2008; U.S. Provisional Patent Application Ser. No. 61/040,994, entitled “FUSING BIOLOGICAL TISSUE WITH HIGH FREQUENCY ELECTRICAL ENERGY”, filed Mar. 31, 2008; U.S. Provisional Patent Application Ser. No. 61/040,957, entitled “METHOD AND APPARATUS FOR BLOODLESS TISSUE DISSECTION”, filed Mar. 31, 2008; U.S. Provisional Patent Application Ser. No. 61/040,828, entitled “LAPAROSCOPIC BIPOLAR ELECTRICAL INSTRUMENT”, filed Mar. 31, 2008; U.S. Provisional Patent Application Ser. No. 61/040,890, entitled “APPARATUS AND METHOD FOR FUSION OF LIVING TISSUE”, filed Mar. 31, 2008; U.S. Provisional Patent Application Ser. No. 61/041,045, entitled “WELDING BIOLOGICAL TISSUE WITH HIGH FREQUENCY ELECTRICAL ENERGY”, filed Mar. 31, 2008; U.S. Provisional Patent Application Ser. No. 61/041,012, entitled “ELECTRICAL CONTROL CIRCUIT FOR FUSING OF BIOLOGICAL TISSUE WITH HIGH FREQUENCY ELECTRICAL ENERGY”, filed Mar. 31, 2008; U.S. Provisional Patent Application Ser. No. 61/115,756, entitled “METHOD AND APPARATUS FOR ELECTROSURGICAL TISSUE DISSECTION”, filed Nov. 18, 2008. All of these applications are incorporated herein by reference in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
371664 | Brannan et al. | Oct 1887 | A |
702472 | Pignolet | Jun 1902 | A |
728883 | Downes | May 1903 | A |
1586645 | Bierman | Jun 1926 | A |
1935289 | Evans | Apr 1933 | A |
2002594 | Wappler et al. | May 1935 | A |
2031682 | Wappler et al. | Feb 1936 | A |
2113246 | Wappler | Apr 1938 | A |
2176479 | Willis | Oct 1939 | A |
2305156 | Grubel | Apr 1941 | A |
2632661 | Cristofv | Mar 1953 | A |
2827056 | Degelman | Mar 1958 | A |
3085566 | Tolles | Apr 1963 | A |
3459187 | Pallotta | Aug 1969 | A |
3494363 | Jackson | Feb 1970 | A |
3588710 | Masters | Jun 1971 | A |
3651811 | Hildebrandt et al. | Mar 1972 | A |
3685518 | Beuerle et al. | Aug 1972 | A |
3780416 | Rider | Dec 1973 | A |
3826263 | Cage et al. | Jul 1974 | A |
3911766 | Fridolph | Oct 1975 | A |
3920021 | Hiltebrandt | Nov 1975 | A |
3938527 | Rioux | Feb 1976 | A |
3963030 | Newton | Jun 1976 | A |
3970088 | Morrison | Jul 1976 | A |
3980085 | Ikuno | Sep 1976 | A |
3987795 | Morrison | Oct 1976 | A |
4030501 | Archibald | Jun 1977 | A |
4041952 | Morrison, Jr. et al. | Aug 1977 | A |
4043342 | Morrison | Aug 1977 | A |
4060088 | Morrison, Jr. et al. | Nov 1977 | A |
4074718 | Morrison, Jr. | Feb 1978 | A |
4089336 | Cage et al. | May 1978 | A |
4092986 | Schneiderman | Jun 1978 | A |
4094320 | Newton et al. | Jun 1978 | A |
4114623 | Meinke | Sep 1978 | A |
4126137 | Archibald | Nov 1978 | A |
4154240 | Ikuno | May 1979 | A |
4171700 | Farin | Oct 1979 | A |
4181131 | Ogui | Jan 1980 | A |
4188927 | Harris | Feb 1980 | A |
4196734 | Harris | Apr 1980 | A |
4198957 | Cage et al. | Apr 1980 | A |
4198960 | Utsugi | Apr 1980 | A |
4200104 | Harris | Apr 1980 | A |
4231372 | Newton | Nov 1980 | A |
4237887 | Gonser | Dec 1980 | A |
4244371 | Farin | Jan 1981 | A |
4325374 | Komiya | Apr 1982 | A |
4331149 | Gonser | May 1982 | A |
4338940 | Ikuno | Jul 1982 | A |
4352156 | Gyugyi | Sep 1982 | A |
4370980 | Lottick | Feb 1983 | A |
4416276 | Newton | Nov 1983 | A |
4416277 | Newton et al. | Nov 1983 | A |
4427014 | Bel | Jan 1984 | A |
4429694 | McGreevy | Feb 1984 | A |
4463759 | Garito et al. | Aug 1984 | A |
4487489 | Takamatsu | Dec 1984 | A |
4514619 | Kugelman | Apr 1985 | A |
4522206 | Whipple et al. | Jun 1985 | A |
4552143 | Lottick | Nov 1985 | A |
4569131 | Falk et al. | Feb 1986 | A |
4569345 | Manes et al. | Feb 1986 | A |
4590934 | Malis et al. | May 1986 | A |
4599553 | Brennen et al. | Jul 1986 | A |
4630218 | Hurley | Dec 1986 | A |
4632109 | Paterson | Dec 1986 | A |
4644950 | Valli | Feb 1987 | A |
4651280 | Chang et al. | Mar 1987 | A |
4655216 | Tischer | Apr 1987 | A |
4657018 | Hakky | Apr 1987 | A |
4658815 | Farin et al. | Apr 1987 | A |
4658819 | Harris et al. | Apr 1987 | A |
4658820 | Klicek | Apr 1987 | A |
4674498 | Stasz | Jun 1987 | A |
4685459 | Koch et al. | Aug 1987 | A |
4699146 | Sieverding | Oct 1987 | A |
4712545 | Honkanen | Dec 1987 | A |
4716897 | Noguchi et al. | Jan 1988 | A |
4727874 | Bowers | Mar 1988 | A |
4739759 | Rexroth et al. | Apr 1988 | A |
4741334 | Irnich | May 1988 | A |
4752864 | Clappier | Jun 1988 | A |
4754757 | Feucht | Jul 1988 | A |
4788977 | Farin et al. | Dec 1988 | A |
4802476 | Noerenberg et al. | Feb 1989 | A |
4818954 | Flachenecker | Apr 1989 | A |
4827927 | Newton | May 1989 | A |
4848335 | Manes | Jul 1989 | A |
4850353 | Stasz et al. | Jul 1989 | A |
4860745 | Farin et al. | Aug 1989 | A |
4862889 | Feucht | Sep 1989 | A |
4862890 | Stasz et al. | Sep 1989 | A |
4872456 | Hasson | Oct 1989 | A |
4887612 | Esser et al. | Dec 1989 | A |
4889722 | Sheffield et al. | Dec 1989 | A |
4903696 | Stasz et al. | Feb 1990 | A |
4905691 | Rydell | Mar 1990 | A |
4922903 | Welch et al. | May 1990 | A |
4936281 | Stasz | Jun 1990 | A |
4937254 | Sheffield et al. | Jun 1990 | A |
4938761 | Ensslin | Jul 1990 | A |
4942313 | Kinzel | Jul 1990 | A |
4958539 | Stasz et al. | Sep 1990 | A |
4969067 | James | Nov 1990 | A |
4969885 | Farin | Nov 1990 | A |
4976711 | Parins et al. | Dec 1990 | A |
5007908 | Rydell | Apr 1991 | A |
5013312 | Parins et al. | May 1991 | A |
5015227 | Broadwin et al. | May 1991 | A |
5016521 | Haka | May 1991 | A |
5026370 | Lottick | Jun 1991 | A |
5026371 | Rydell et al. | Jun 1991 | A |
5035696 | Rydell | Jul 1991 | A |
5038109 | Goble et al. | Aug 1991 | A |
5047026 | Rydell | Sep 1991 | A |
5047027 | Rydell | Sep 1991 | A |
5052402 | Bencini et al. | Oct 1991 | A |
5057107 | Parins et al. | Oct 1991 | A |
5061269 | Muller | Oct 1991 | A |
5062031 | Flachenecker et al. | Oct 1991 | A |
5071419 | Rydell et al. | Dec 1991 | A |
5078717 | Parins et al. | Jan 1992 | A |
5083565 | Parins | Jan 1992 | A |
5085659 | Rydell | Feb 1992 | A |
5087257 | Farin et al. | Feb 1992 | A |
5098431 | Rydell | Mar 1992 | A |
5116332 | Lottick | May 1992 | A |
5122137 | Lennox | Jun 1992 | A |
5125928 | Parins et al. | Jun 1992 | A |
5127412 | Cosmetto et al. | Jul 1992 | A |
5151102 | Kamiyama et al. | Sep 1992 | A |
5158561 | Rydell et al. | Oct 1992 | A |
5160343 | Brancel et al. | Nov 1992 | A |
5167658 | Ensslin | Dec 1992 | A |
5171255 | Rydell | Dec 1992 | A |
5171311 | Rydell | Dec 1992 | A |
5190517 | Klicek et al. | Mar 1993 | A |
5190541 | Abele et al. | Mar 1993 | A |
5192280 | Parins | Mar 1993 | A |
5197963 | Parins | Mar 1993 | A |
5197964 | Parins | Mar 1993 | A |
5201732 | Parins et al. | Apr 1993 | A |
5217457 | Delahuerga et al. | Jun 1993 | A |
5217458 | Parins | Jun 1993 | A |
5234427 | Ohtomo et al. | Aug 1993 | A |
5244462 | Delahuerga et al. | Sep 1993 | A |
5246440 | Van Noord | Sep 1993 | A |
5250047 | Rydell | Oct 1993 | A |
5250056 | Hasson | Oct 1993 | A |
5254126 | Filipi et al. | Oct 1993 | A |
5256149 | Banik et al. | Oct 1993 | A |
5258006 | Rydell et al. | Nov 1993 | A |
5267997 | Farin et al. | Dec 1993 | A |
5269780 | Roos | Dec 1993 | A |
5273524 | Fox et al. | Dec 1993 | A |
5281216 | Klicek | Jan 1994 | A |
5282799 | Rydell | Feb 1994 | A |
5286255 | Weber | Feb 1994 | A |
5290286 | Parins | Mar 1994 | A |
5300070 | Gentelia et al. | Apr 1994 | A |
5304190 | Reckelhoff et al. | Apr 1994 | A |
5312329 | Beaty et al. | May 1994 | A |
5314424 | Nicholas | May 1994 | A |
5318563 | Malis et al. | Jun 1994 | A |
5322055 | Davison et al. | Jun 1994 | A |
5324289 | Eggers | Jun 1994 | A |
5330471 | Eggers | Jul 1994 | A |
5334183 | Wuchinich | Aug 1994 | A |
5338317 | Hasson et al. | Aug 1994 | A |
5341807 | Nardella | Aug 1994 | A |
5341815 | Cofone et al. | Aug 1994 | A |
5342359 | Rydell | Aug 1994 | A |
5342381 | Tidemand | Aug 1994 | A |
5352222 | Rydell | Oct 1994 | A |
5352223 | McBrayer et al. | Oct 1994 | A |
5354313 | Boebel | Oct 1994 | A |
5356408 | Rydell | Oct 1994 | A |
5370645 | Klicek et al. | Dec 1994 | A |
5372124 | Takayama et al. | Dec 1994 | A |
5372596 | Klicek et al. | Dec 1994 | A |
5374277 | Hassler | Dec 1994 | A |
5382247 | Cimino et al. | Jan 1995 | A |
5383880 | Hovven | Jan 1995 | A |
5383922 | Zipes et al. | Jan 1995 | A |
5387196 | Green et al. | Feb 1995 | A |
5387197 | Smith et al. | Feb 1995 | A |
5389104 | Hahnen et al. | Feb 1995 | A |
5389849 | Asano et al. | Feb 1995 | A |
5391166 | Eggers | Feb 1995 | A |
5392917 | Alpern et al. | Feb 1995 | A |
5400267 | Denen | Mar 1995 | A |
5403312 | Yates | Apr 1995 | A |
5403342 | Tovey et al. | Apr 1995 | A |
5405344 | Williamson et al. | Apr 1995 | A |
5409498 | Braddock et al. | Apr 1995 | A |
5422567 | Matsunaga | Jun 1995 | A |
5423808 | Edwards et al. | Jun 1995 | A |
5423810 | Goble et al. | Jun 1995 | A |
5431638 | Hennig et al. | Jul 1995 | A |
5431649 | Mulier et al. | Jul 1995 | A |
5431674 | Basile et al. | Jul 1995 | A |
5432459 | Thompson et al. | Jul 1995 | A |
5436566 | Thompson et al. | Jul 1995 | A |
5437664 | Cohen et al. | Aug 1995 | A |
5438302 | Goble | Aug 1995 | A |
5443463 | Stern et al. | Aug 1995 | A |
5445142 | Hassler, Jr. | Aug 1995 | A |
5445638 | Rydell et al. | Aug 1995 | A |
5447513 | Davison et al. | Sep 1995 | A |
5449355 | Rhum et al. | Sep 1995 | A |
5456684 | Schmidt et al. | Oct 1995 | A |
5458598 | Feinberg et al. | Oct 1995 | A |
5460182 | Goodman et al. | Oct 1995 | A |
5462546 | Rydell | Oct 1995 | A |
5464144 | Guy et al. | Nov 1995 | A |
5472439 | Hurd | Dec 1995 | A |
5472442 | Klicek | Dec 1995 | A |
5472443 | Cordis et al. | Dec 1995 | A |
5472451 | Freitas et al. | Dec 1995 | A |
5474057 | Makower et al. | Dec 1995 | A |
5476479 | Green et al. | Dec 1995 | A |
5478351 | Meade et al. | Dec 1995 | A |
5486185 | Freitas et al. | Jan 1996 | A |
5496312 | Klicek | Mar 1996 | A |
5496317 | Goble et al. | Mar 1996 | A |
5499992 | Meade et al. | Mar 1996 | A |
5499998 | Meade et al. | Mar 1996 | A |
5503320 | Webster et al. | Apr 1996 | A |
5507773 | Hutema et al. | Apr 1996 | A |
5509916 | Taylor | Apr 1996 | A |
5514129 | Smith | May 1996 | A |
5514134 | Rydell et al. | May 1996 | A |
5515163 | Kupershmidt et al. | May 1996 | A |
5518164 | Hooven | May 1996 | A |
5527313 | Scott et al. | Jun 1996 | A |
5527330 | Tovey | Jun 1996 | A |
5531744 | Nardella et al. | Jul 1996 | A |
5540681 | Strul et al. | Jul 1996 | A |
5540684 | Hassler | Jul 1996 | A |
5540685 | Parins et al. | Jul 1996 | A |
5541376 | Ladtkow et al. | Jul 1996 | A |
5551945 | Yabe et al. | Sep 1996 | A |
5558429 | Cain | Sep 1996 | A |
5558671 | Yates | Sep 1996 | A |
5562699 | Heimberger et al. | Oct 1996 | A |
5562700 | Huitema et al. | Oct 1996 | A |
5571100 | Goble et al. | Nov 1996 | A |
5571121 | Heifetz | Nov 1996 | A |
5573424 | Poppe | Nov 1996 | A |
5573533 | Strul | Nov 1996 | A |
5573534 | Stone | Nov 1996 | A |
5573535 | Viklund | Nov 1996 | A |
5575789 | Bell et al. | Nov 1996 | A |
5575805 | Li | Nov 1996 | A |
5584830 | Ladd et al. | Dec 1996 | A |
5599344 | Paterson | Feb 1997 | A |
5599350 | Schulze et al. | Feb 1997 | A |
5603711 | Parins et al. | Feb 1997 | A |
D378611 | Croley | Mar 1997 | S |
5607391 | Klinger et al. | Mar 1997 | A |
5609151 | Mulier et al. | Mar 1997 | A |
5609560 | Ichikawa et al. | Mar 1997 | A |
5609573 | Sandock | Mar 1997 | A |
5611709 | McAnulty | Mar 1997 | A |
5613966 | Makower et al. | Mar 1997 | A |
5620415 | Lucey et al. | Apr 1997 | A |
5620447 | Smith et al. | Apr 1997 | A |
5624452 | Yates | Apr 1997 | A |
5626575 | Crenner | May 1997 | A |
5626607 | Malecki et al. | May 1997 | A |
5626608 | Cuny et al. | May 1997 | A |
5627584 | Nishikori et al. | May 1997 | A |
5633578 | Eggers et al. | May 1997 | A |
5645540 | Henniges et al. | Jul 1997 | A |
5647869 | Goble et al. | Jul 1997 | A |
5651780 | Jackson et al. | Jul 1997 | A |
5658279 | Nardella et al. | Aug 1997 | A |
5658281 | Heard | Aug 1997 | A |
5665100 | Yoon | Sep 1997 | A |
5665105 | Furnish et al. | Sep 1997 | A |
5667517 | Hooven | Sep 1997 | A |
5669907 | Platt, Jr. et al. | Sep 1997 | A |
5674184 | Hassler, Jr. | Oct 1997 | A |
5674220 | Fox et al. | Oct 1997 | A |
5683349 | Makower et al. | Nov 1997 | A |
5688270 | Yates et al. | Nov 1997 | A |
5693045 | Eggers | Dec 1997 | A |
5693051 | Schulze et al. | Dec 1997 | A |
5695494 | Becker | Dec 1997 | A |
5697281 | Eggers et al. | Dec 1997 | A |
5697909 | Eggers et al. | Dec 1997 | A |
5700261 | Brinkerhoff | Dec 1997 | A |
5702386 | Stern et al. | Dec 1997 | A |
5702387 | Arts et al. | Dec 1997 | A |
5702390 | Austin et al. | Dec 1997 | A |
5707369 | Vaitekunas et al. | Jan 1998 | A |
5709680 | Yates et al. | Jan 1998 | A |
5713128 | Schrenk et al. | Feb 1998 | A |
5713895 | Lontine et al. | Feb 1998 | A |
5713896 | Nardella | Feb 1998 | A |
5720742 | Zacharias | Feb 1998 | A |
5720744 | Eggleston et al. | Feb 1998 | A |
5720745 | Farin et al. | Feb 1998 | A |
5722659 | Gluth | Mar 1998 | A |
5722975 | Edwards et al. | Mar 1998 | A |
5725524 | Mulier et al. | Mar 1998 | A |
5735848 | Yates et al. | Apr 1998 | A |
5735849 | Baden et al. | Apr 1998 | A |
5743456 | Jones et al. | Apr 1998 | A |
5743906 | Parins et al. | Apr 1998 | A |
5746210 | Benaron et al. | May 1998 | A |
5746740 | Nicholas | May 1998 | A |
5746759 | Meade et al. | May 1998 | A |
5752519 | Benaron et al. | May 1998 | A |
5755717 | Yates et al. | May 1998 | A |
5759185 | Grinberg | Jun 1998 | A |
5762609 | Benaron et al. | Jun 1998 | A |
5766167 | Eggers et al. | Jun 1998 | A |
5769791 | Benaron et al. | Jun 1998 | A |
5769841 | Odell et al. | Jun 1998 | A |
5772597 | Goldberger et al. | Jun 1998 | A |
5772660 | Young et al. | Jun 1998 | A |
5776092 | Farin et al. | Jul 1998 | A |
5776129 | Mersch | Jul 1998 | A |
5776130 | Buysse et al. | Jul 1998 | A |
5776155 | Beaupre et al. | Jul 1998 | A |
5782397 | Koukline | Jul 1998 | A |
5785658 | Benaron et al. | Jul 1998 | A |
5792139 | Chambers et al. | Aug 1998 | A |
5792178 | Welch et al. | Aug 1998 | A |
5797906 | Rhum et al. | Aug 1998 | A |
5797938 | Paraschac et al. | Aug 1998 | A |
5797941 | Schulze | Aug 1998 | A |
5800449 | Wales | Sep 1998 | A |
5807261 | Benaron et al. | Sep 1998 | A |
5807393 | Williamson, IV et al. | Sep 1998 | A |
5807395 | Mulier et al. | Sep 1998 | A |
5810806 | Ritchart et al. | Sep 1998 | A |
5810811 | Yates et al. | Sep 1998 | A |
5810859 | Dimatteo et al. | Sep 1998 | A |
5817091 | Nardella et al. | Oct 1998 | A |
5817093 | Williamson, IV et al. | Oct 1998 | A |
5817119 | Klieman et al. | Oct 1998 | A |
5827271 | Buysse et al. | Oct 1998 | A |
5827279 | Hughett et al. | Oct 1998 | A |
5827299 | Thomason et al. | Oct 1998 | A |
5830231 | Geiges, Jr. | Nov 1998 | A |
5833690 | Yates et al. | Nov 1998 | A |
5836942 | Netherly et al. | Nov 1998 | A |
5836943 | Miller, III | Nov 1998 | A |
5846194 | Wasson et al. | Dec 1998 | A |
5849020 | Long et al. | Dec 1998 | A |
5853412 | Mayenberger | Dec 1998 | A |
5860975 | Goble et al. | Jan 1999 | A |
5873873 | Smith et al. | Feb 1999 | A |
5876398 | Mulier et al. | Mar 1999 | A |
5876401 | Schulze et al. | Mar 1999 | A |
5885277 | Korth | Mar 1999 | A |
5891095 | Eggers et al. | Apr 1999 | A |
5891141 | Rydell | Apr 1999 | A |
5891142 | Eggers et al. | Apr 1999 | A |
5893835 | Witt et al. | Apr 1999 | A |
5893873 | Rader et al. | Apr 1999 | A |
5897490 | Fox et al. | Apr 1999 | A |
5897523 | Wright et al. | Apr 1999 | A |
5897553 | Mulier et al. | Apr 1999 | A |
5897569 | Kellogg et al. | Apr 1999 | A |
5902264 | Toso et al. | May 1999 | A |
5902301 | Olig | May 1999 | A |
5906613 | Mulier et al. | May 1999 | A |
5908402 | Blythe | Jun 1999 | A |
5908420 | Parins et al. | Jun 1999 | A |
5910152 | Bays | Jun 1999 | A |
5928137 | Green | Jul 1999 | A |
5928255 | Meade et al. | Jul 1999 | A |
5928256 | Riza | Jul 1999 | A |
5931836 | Hatta et al. | Aug 1999 | A |
5935126 | Riza | Aug 1999 | A |
5938633 | Beaupre | Aug 1999 | A |
5944715 | Goble et al. | Aug 1999 | A |
5944718 | Austin et al. | Aug 1999 | A |
5944737 | Tsonton et al. | Aug 1999 | A |
5947284 | Foster | Sep 1999 | A |
5947984 | Whipple | Sep 1999 | A |
5951552 | Long et al. | Sep 1999 | A |
5954736 | Bishop et al. | Sep 1999 | A |
5954746 | Holthaus et al. | Sep 1999 | A |
5957943 | Vaitekunas | Sep 1999 | A |
5961514 | Long et al. | Oct 1999 | A |
5968062 | Thomas et al. | Oct 1999 | A |
5968074 | Prestel | Oct 1999 | A |
5976077 | Wittens et al. | Nov 1999 | A |
5976128 | Schilling et al. | Nov 1999 | A |
5980510 | Tsonton et al. | Nov 1999 | A |
5980516 | Mulier et al. | Nov 1999 | A |
5984921 | Long et al. | Nov 1999 | A |
5987346 | Benaron et al. | Nov 1999 | A |
5993380 | Yabe et al. | Nov 1999 | A |
5993447 | Blewett et al. | Nov 1999 | A |
5995875 | Blewett et al. | Nov 1999 | A |
5997533 | Kuhns | Dec 1999 | A |
6003517 | Sheffield et al. | Dec 1999 | A |
6004319 | Goble et al. | Dec 1999 | A |
6004335 | Vaitekunas et al. | Dec 1999 | A |
6010499 | Cobb | Jan 2000 | A |
6010516 | Hulka | Jan 2000 | A |
6012909 | Sloteman et al. | Jan 2000 | A |
6013076 | Goble et al. | Jan 2000 | A |
6015406 | Goble et al. | Jan 2000 | A |
6016809 | Mulier et al. | Jan 2000 | A |
D420741 | Croley | Feb 2000 | S |
6024741 | Williamson, IV et al. | Feb 2000 | A |
6024744 | Kese et al. | Feb 2000 | A |
6027501 | Goble et al. | Feb 2000 | A |
6027522 | Palmer | Feb 2000 | A |
6030384 | Nezhat | Feb 2000 | A |
6030402 | Thompson et al. | Feb 2000 | A |
6033399 | Gines | Mar 2000 | A |
6033404 | Melzer et al. | Mar 2000 | A |
6036657 | Milliman et al. | Mar 2000 | A |
6039733 | Buysse et al. | Mar 2000 | A |
6039734 | Goble | Mar 2000 | A |
6039736 | Platt, Jr. | Mar 2000 | A |
6050996 | Schmaltz et al. | Apr 2000 | A |
6051010 | Dimatteo et al. | Apr 2000 | A |
6053914 | Eggers et al. | Apr 2000 | A |
6056746 | Goble et al. | May 2000 | A |
6063050 | Manna et al. | May 2000 | A |
6063075 | Mohori | May 2000 | A |
6063081 | Mulier et al. | May 2000 | A |
6063086 | Benecke et al. | May 2000 | A |
6066139 | Ryan et al. | May 2000 | A |
6068627 | Orszulak et al. | May 2000 | A |
6068647 | Witt et al. | May 2000 | A |
6070444 | Lontine et al. | Jun 2000 | A |
6074386 | Goble et al. | Jun 2000 | A |
RE36795 | Rydell | Jul 2000 | E |
6083191 | Rose | Jul 2000 | A |
6086586 | Hooven | Jul 2000 | A |
6090106 | Goble et al. | Jul 2000 | A |
6090120 | Wright et al. | Jul 2000 | A |
6092722 | Heinrichs et al. | Jul 2000 | A |
6093186 | Goble | Jul 2000 | A |
6096037 | Mulier et al. | Aug 2000 | A |
6106521 | Blewett et al. | Aug 2000 | A |
6109268 | Thapliyal et al. | Aug 2000 | A |
6110171 | Rydell | Aug 2000 | A |
6113591 | Whayne et al. | Sep 2000 | A |
6113594 | Savage | Sep 2000 | A |
6113596 | Hooven et al. | Sep 2000 | A |
6113598 | Baker | Sep 2000 | A |
6117152 | Huitema | Sep 2000 | A |
6120501 | Long et al. | Sep 2000 | A |
H1904 | Yates | Oct 2000 | H |
6132429 | Baker | Oct 2000 | A |
6135998 | Palanker | Oct 2000 | A |
6139519 | Blythe | Oct 2000 | A |
6139547 | Lontine et al. | Oct 2000 | A |
6142992 | Cheng et al. | Nov 2000 | A |
6152923 | Ryan | Nov 2000 | A |
6159146 | El Gazayerli | Dec 2000 | A |
6162235 | Vaitekunas | Dec 2000 | A |
6165175 | Wampler et al. | Dec 2000 | A |
6168605 | Measamer et al. | Jan 2001 | B1 |
6171304 | Netherly et al. | Jan 2001 | B1 |
6174308 | Goble et al. | Jan 2001 | B1 |
6174309 | Wrublewski et al. | Jan 2001 | B1 |
6179834 | Buysse et al. | Jan 2001 | B1 |
6186147 | Cobb | Feb 2001 | B1 |
6187003 | Buysse et al. | Feb 2001 | B1 |
6187026 | Devlin et al. | Feb 2001 | B1 |
6190383 | Schmaltz et al. | Feb 2001 | B1 |
6190385 | Tom et al. | Feb 2001 | B1 |
6190386 | Rydell | Feb 2001 | B1 |
6193129 | Bittner et al. | Feb 2001 | B1 |
6193653 | Evans et al. | Feb 2001 | B1 |
6193713 | Geistert et al. | Feb 2001 | B1 |
6197026 | Farin et al. | Mar 2001 | B1 |
6203541 | Keppel | Mar 2001 | B1 |
6206823 | Kolata et al. | Mar 2001 | B1 |
6206844 | Reichel et al. | Mar 2001 | B1 |
6206875 | Long et al. | Mar 2001 | B1 |
6206877 | Kese et al. | Mar 2001 | B1 |
6210403 | Klicek | Apr 2001 | B1 |
6210405 | Goble et al. | Apr 2001 | B1 |
6214003 | Morgan et al. | Apr 2001 | B1 |
6214023 | Whipple et al. | Apr 2001 | B1 |
6228023 | Zaslavsky et al. | May 2001 | B1 |
6228055 | Foerster et al. | May 2001 | B1 |
6228080 | Gines | May 2001 | B1 |
6228081 | Goble | May 2001 | B1 |
6228083 | Lands et al. | May 2001 | B1 |
6234178 | Goble et al. | May 2001 | B1 |
6237604 | Burnside et al. | May 2001 | B1 |
6238366 | Savage et al. | May 2001 | B1 |
6238392 | Long | May 2001 | B1 |
6238393 | Mulier et al. | May 2001 | B1 |
6242741 | Miller et al. | Jun 2001 | B1 |
6246912 | Sluijter et al. | Jun 2001 | B1 |
6251106 | Becker et al. | Jun 2001 | B1 |
6251110 | Wampler | Jun 2001 | B1 |
6254623 | Haibel et al. | Jul 2001 | B1 |
6257241 | Wampler | Jul 2001 | B1 |
6258085 | Eggleston | Jul 2001 | B1 |
6261286 | Goble et al. | Jul 2001 | B1 |
6267761 | Ryan | Jul 2001 | B1 |
6270497 | Sekino et al. | Aug 2001 | B1 |
6273862 | Privitera et al. | Aug 2001 | B1 |
6277114 | Bullivant et al. | Aug 2001 | B1 |
6277115 | Saadat | Aug 2001 | B1 |
6277117 | Tetzlaff et al. | Aug 2001 | B1 |
6280398 | Ritchart et al. | Aug 2001 | B1 |
6280407 | Manna et al. | Aug 2001 | B1 |
6280441 | Ryan | Aug 2001 | B1 |
6283963 | Regula | Sep 2001 | B1 |
6287344 | Wampler | Sep 2001 | B1 |
6293942 | Goble et al. | Sep 2001 | B1 |
6293945 | Parins et al. | Sep 2001 | B1 |
6296637 | Thorne et al. | Oct 2001 | B1 |
6296640 | Wampler et al. | Oct 2001 | B1 |
6298550 | Kirwan, Jr. | Oct 2001 | B1 |
6302903 | Mulier et al. | Oct 2001 | B1 |
6306131 | Hareyama et al. | Oct 2001 | B1 |
6306134 | Goble et al. | Oct 2001 | B1 |
6308089 | von der Ruhr et al. | Oct 2001 | B1 |
6309400 | Beaupre | Oct 2001 | B2 |
6312426 | Goldberg et al. | Nov 2001 | B1 |
6315777 | Comben | Nov 2001 | B1 |
6319221 | Savage et al. | Nov 2001 | B1 |
6322494 | Bullivant et al. | Nov 2001 | B1 |
6322549 | Eggers et al. | Nov 2001 | B1 |
6322561 | Eggers et al. | Nov 2001 | B1 |
6325795 | Lindemann et al. | Dec 2001 | B1 |
6325799 | Goble | Dec 2001 | B1 |
6325811 | Messerly | Dec 2001 | B1 |
6328736 | Mulier et al. | Dec 2001 | B1 |
6328751 | Beaupre | Dec 2001 | B1 |
6331181 | Tierney et al. | Dec 2001 | B1 |
6334068 | Hacker | Dec 2001 | B1 |
6334861 | Chandler et al. | Jan 2002 | B1 |
6336926 | Goble et al. | Jan 2002 | B1 |
6348051 | Farin et al. | Feb 2002 | B1 |
6352532 | Kramer et al. | Mar 2002 | B1 |
6352536 | Buysse et al. | Mar 2002 | B1 |
6358248 | Mulier et al. | Mar 2002 | B1 |
6358249 | Chen et al. | Mar 2002 | B1 |
6358267 | Murakami | Mar 2002 | B1 |
6361534 | Chen et al. | Mar 2002 | B1 |
6364877 | Goble et al. | Apr 2002 | B1 |
6364879 | Chen et al. | Apr 2002 | B1 |
6371967 | Long et al. | Apr 2002 | B1 |
D457958 | Dycus | May 2002 | S |
6383183 | Sekino et al. | May 2002 | B1 |
6387092 | Burnside et al. | May 2002 | B1 |
6387109 | Davison et al. | May 2002 | B1 |
6391025 | Weinstein et al. | May 2002 | B1 |
6398779 | Buysse et al. | Jun 2002 | B1 |
6398781 | Goble et al. | Jun 2002 | B1 |
6402741 | Keppel et al. | Jun 2002 | B1 |
6402742 | Blewett et al. | Jun 2002 | B1 |
6402743 | Orszulak et al. | Jun 2002 | B1 |
6402747 | Lindemann et al. | Jun 2002 | B1 |
6402748 | Schoenman et al. | Jun 2002 | B1 |
6406475 | Wenzler et al. | Jun 2002 | B1 |
6409722 | Hoey et al. | Jun 2002 | B1 |
6409724 | Penny et al. | Jun 2002 | B1 |
6409728 | Ehr et al. | Jun 2002 | B1 |
6416486 | Wampler | Jul 2002 | B1 |
6416509 | Goble et al. | Jul 2002 | B1 |
6417687 | Heinrich | Jul 2002 | B1 |
6423082 | Houser et al. | Jul 2002 | B1 |
6432118 | Messerly | Aug 2002 | B1 |
6436096 | Hareyama | Aug 2002 | B1 |
6440130 | Mulier et al. | Aug 2002 | B1 |
6443952 | Mulier et al. | Sep 2002 | B1 |
6443968 | Holthaus et al. | Sep 2002 | B1 |
6443970 | Schulze et al. | Sep 2002 | B1 |
6451013 | Bays et al. | Sep 2002 | B1 |
6451018 | Lands et al. | Sep 2002 | B1 |
6454764 | Fleenor et al. | Sep 2002 | B1 |
6454781 | Witt et al. | Sep 2002 | B1 |
6454782 | Schwemberger | Sep 2002 | B1 |
6458078 | Ludtke et al. | Oct 2002 | B1 |
6458128 | Schulze | Oct 2002 | B1 |
6458130 | Frazier et al. | Oct 2002 | B1 |
6458142 | Faller et al. | Oct 2002 | B1 |
6461352 | Morgan et al. | Oct 2002 | B2 |
6464689 | Qin et al. | Oct 2002 | B1 |
6464702 | Schulze et al. | Oct 2002 | B2 |
6464704 | Schmaltz et al. | Oct 2002 | B2 |
6468275 | Wampler et al. | Oct 2002 | B1 |
6468286 | Mastri et al. | Oct 2002 | B2 |
6475217 | Platt | Nov 2002 | B1 |
6478030 | Shaoeton et al. | Nov 2002 | B1 |
6482202 | Goble et al. | Nov 2002 | B1 |
6485490 | Wampler et al. | Nov 2002 | B2 |
6488507 | Stoloff et al. | Dec 2002 | B1 |
6488680 | Francischelli et al. | Dec 2002 | B1 |
6491690 | Goble et al. | Dec 2002 | B1 |
6491708 | Madan et al. | Dec 2002 | B2 |
6493589 | Medhkour et al. | Dec 2002 | B1 |
6494877 | Odell et al. | Dec 2002 | B2 |
6494902 | Hoey et al. | Dec 2002 | B2 |
6497705 | Comben | Dec 2002 | B2 |
6500176 | Truckai et al. | Dec 2002 | B1 |
6500188 | Harper et al. | Dec 2002 | B2 |
6503263 | Adams | Jan 2003 | B2 |
6506189 | Rittman et al. | Jan 2003 | B1 |
6506208 | Hunt et al. | Jan 2003 | B2 |
6510854 | Goble et al. | Jan 2003 | B2 |
6511476 | Hareyama | Jan 2003 | B2 |
6511480 | Tetzlaff et al. | Jan 2003 | B1 |
6514252 | Nezhat et al. | Feb 2003 | B2 |
6517536 | Hooven et al. | Feb 2003 | B2 |
6526320 | Mitchell | Feb 2003 | B2 |
6527771 | Weadock et al. | Mar 2003 | B1 |
6533784 | Truckai et al. | Mar 2003 | B2 |
6534770 | Miller et al. | Mar 2003 | B2 |
6537248 | Mulier et al. | Mar 2003 | B2 |
6537272 | Christopherson et al. | Mar 2003 | B2 |
6540695 | Burbank et al. | Apr 2003 | B1 |
6543456 | Freeman | Apr 2003 | B1 |
6547783 | Vilendrer et al. | Apr 2003 | B1 |
6547786 | Goble et al. | Apr 2003 | B1 |
6554829 | Schulze et al. | Apr 2003 | B2 |
6558379 | Batchelor et al. | May 2003 | B1 |
6558383 | Cunningham et al. | May 2003 | B2 |
6561983 | Cronin et al. | May 2003 | B2 |
6562037 | Paton et al. | May 2003 | B2 |
6565559 | Eggleston | May 2003 | B2 |
6565560 | Goble et al. | May 2003 | B1 |
6569105 | Kortenbach et al. | May 2003 | B1 |
6569109 | Sakurai et al. | May 2003 | B2 |
6572615 | Schulze et al. | Jun 2003 | B2 |
6579289 | Schnitzler | Jun 2003 | B2 |
6582424 | Fleenor et al. | Jun 2003 | B2 |
6582427 | Goble et al. | Jun 2003 | B1 |
6584360 | Francischelli et al. | Jun 2003 | B2 |
D477408 | Bromley | Jul 2003 | S |
6585732 | Mulier et al. | Jul 2003 | B2 |
6585733 | Wellman | Jul 2003 | B2 |
6585735 | Frazier et al. | Jul 2003 | B1 |
6589200 | Schwemberger et al. | Jul 2003 | B1 |
6591719 | Poole et al. | Jul 2003 | B1 |
6592582 | Hess et al. | Jul 2003 | B2 |
6594518 | Benaron et al. | Jul 2003 | B1 |
6602227 | Cimino et al. | Aug 2003 | B1 |
6602249 | Stoddard et al. | Aug 2003 | B1 |
6602252 | Mollenauer | Aug 2003 | B2 |
6605036 | Wild | Aug 2003 | B1 |
6607529 | Jones et al. | Aug 2003 | B1 |
6610060 | Mulier et al. | Aug 2003 | B2 |
6611793 | Burnside et al. | Aug 2003 | B1 |
6613048 | Mulier et al. | Sep 2003 | B2 |
6616656 | Brommersma | Sep 2003 | B2 |
6616660 | Platt | Sep 2003 | B1 |
6616661 | Wellman et al. | Sep 2003 | B2 |
6620157 | Dabney et al. | Sep 2003 | B1 |
6620161 | Schulze et al. | Sep 2003 | B2 |
6623482 | Pendekanti et al. | Sep 2003 | B2 |
6623515 | Mulier et al. | Sep 2003 | B2 |
6626901 | Treat et al. | Sep 2003 | B1 |
6629974 | Penny et al. | Oct 2003 | B2 |
6638274 | Yamamoto | Oct 2003 | B2 |
6648883 | Francischelli et al. | Nov 2003 | B2 |
6652514 | Ellman et al. | Nov 2003 | B2 |
6652521 | Schulze | Nov 2003 | B2 |
6656110 | Irion et al. | Dec 2003 | B1 |
6656175 | Francischelli et al. | Dec 2003 | B2 |
6656176 | Hess et al. | Dec 2003 | B2 |
6656177 | Truckai et al. | Dec 2003 | B2 |
6660017 | Beaupre | Dec 2003 | B2 |
6662050 | Olson | Dec 2003 | B2 |
6662127 | Wiener et al. | Dec 2003 | B2 |
6663622 | Foley et al. | Dec 2003 | B1 |
6663627 | Francischelli et al. | Dec 2003 | B2 |
6663628 | Peters | Dec 2003 | B2 |
6666865 | Platt | Dec 2003 | B2 |
6676660 | Wampler et al. | Jan 2004 | B2 |
6678621 | Wiener et al. | Jan 2004 | B2 |
6679882 | Kornerup | Jan 2004 | B1 |
6682527 | Strul | Jan 2004 | B2 |
6682528 | Frazier et al. | Jan 2004 | B2 |
6682544 | Mastri et al. | Jan 2004 | B2 |
6685701 | Orszulak et al. | Feb 2004 | B2 |
6685703 | Pearson et al. | Feb 2004 | B2 |
6692450 | Coleman | Feb 2004 | B1 |
6692489 | Heim et al. | Feb 2004 | B1 |
6695837 | Howell | Feb 2004 | B2 |
6695838 | Wellman et al. | Feb 2004 | B2 |
6695840 | Schulze | Feb 2004 | B2 |
6699240 | Francischelli et al. | Mar 2004 | B2 |
6706038 | Francischelli et al. | Mar 2004 | B2 |
6706039 | Mulier et al. | Mar 2004 | B2 |
6709432 | Ferek-Patric | Mar 2004 | B2 |
6723091 | Goble et al. | Apr 2004 | B2 |
6726683 | Shaw | Apr 2004 | B1 |
6726686 | Buysse et al. | Apr 2004 | B2 |
6733498 | Paton et al. | May 2004 | B2 |
6736810 | Hoey et al. | May 2004 | B2 |
6740084 | Ryan | May 2004 | B2 |
6740085 | Hareyama et al. | May 2004 | B2 |
6740102 | Hess et al. | May 2004 | B2 |
6743229 | Buysse et al. | Jun 2004 | B2 |
6752804 | Simpson et al. | Jun 2004 | B2 |
6755825 | Schoenman et al. | Jun 2004 | B2 |
6755827 | Mulier et al. | Jun 2004 | B2 |
6755841 | Fraser et al. | Jun 2004 | B2 |
6758846 | Goble et al. | Jul 2004 | B2 |
6764487 | Mulier et al. | Jul 2004 | B2 |
6770071 | Woloszko et al. | Aug 2004 | B2 |
6770072 | Truckai et al. | Aug 2004 | B1 |
6773409 | Truckai et al. | Aug 2004 | B2 |
6773434 | Ciarrocca | Aug 2004 | B2 |
6773435 | Schulze et al. | Aug 2004 | B2 |
6773444 | Messerly | Aug 2004 | B2 |
6775575 | Bommannan et al. | Aug 2004 | B2 |
6776780 | Mulier et al. | Aug 2004 | B2 |
6780180 | Goble et al. | Aug 2004 | B1 |
6786906 | Cobb | Sep 2004 | B1 |
6790217 | Schulze et al. | Sep 2004 | B2 |
6796828 | Ehr et al. | Sep 2004 | B2 |
6796981 | Wham et al. | Sep 2004 | B2 |
6807444 | Tu et al. | Oct 2004 | B2 |
6807968 | Francischelli et al. | Oct 2004 | B2 |
6808518 | Wellman et al. | Oct 2004 | B2 |
6808525 | Latterell et al. | Oct 2004 | B2 |
6814745 | Prestel | Nov 2004 | B2 |
6821273 | Mollenauer | Nov 2004 | B2 |
6827715 | Francischelli et al. | Dec 2004 | B2 |
6827717 | Brommersma et al. | Dec 2004 | B2 |
6827725 | Batchelor et al. | Dec 2004 | B2 |
6830569 | Thompson et al. | Dec 2004 | B2 |
6832111 | Tu et al. | Dec 2004 | B2 |
6832985 | Irion et al. | Dec 2004 | B2 |
6832998 | Goble | Dec 2004 | B2 |
6835082 | Gonnering | Dec 2004 | B2 |
6835195 | Schulze et al. | Dec 2004 | B2 |
6837887 | Woloszko et al. | Jan 2005 | B2 |
6843789 | Goble | Jan 2005 | B2 |
6849073 | Hoy et al. | Feb 2005 | B2 |
6852112 | Platt | Feb 2005 | B2 |
6855142 | Harano et al. | Feb 2005 | B2 |
6855145 | Ciarrocca | Feb 2005 | B2 |
6858028 | Mulier et al. | Feb 2005 | B2 |
6860881 | Sturm | Mar 2005 | B2 |
6860894 | Pittman | Mar 2005 | B1 |
6887240 | Lands et al. | May 2005 | B1 |
6889694 | Hooven | May 2005 | B2 |
6893435 | Goble | May 2005 | B2 |
6893441 | Brommersma et al. | May 2005 | B2 |
6899710 | Hooven | May 2005 | B2 |
6905497 | Truckai et al. | Jun 2005 | B2 |
6905498 | Hooven | Jun 2005 | B2 |
6908472 | Wiener et al. | Jun 2005 | B2 |
6911019 | Mulier et al. | Jun 2005 | B2 |
6913579 | Truckai et al. | Jul 2005 | B2 |
6916318 | Francischelli et al. | Jul 2005 | B2 |
6918880 | Brookner et al. | Jul 2005 | B2 |
6923803 | Goble | Aug 2005 | B2 |
6923804 | Eggers et al. | Aug 2005 | B2 |
6923806 | Hooven et al. | Aug 2005 | B2 |
6926716 | Baker et al. | Aug 2005 | B2 |
6929641 | Goble et al. | Aug 2005 | B2 |
6929644 | Truckai et al. | Aug 2005 | B2 |
6932810 | Ryan | Aug 2005 | B2 |
6932811 | Hooven et al. | Aug 2005 | B2 |
6937033 | Boronkay et al. | Aug 2005 | B2 |
6939347 | Thompson | Sep 2005 | B2 |
6942660 | Pantera et al. | Sep 2005 | B2 |
6942662 | Goble et al. | Sep 2005 | B2 |
6945972 | Frigg et al. | Sep 2005 | B2 |
6945981 | Donofrio et al. | Sep 2005 | B2 |
6948503 | Refior et al. | Sep 2005 | B2 |
6949098 | Mulier et al. | Sep 2005 | B2 |
6958063 | Soll et al. | Oct 2005 | B1 |
6960209 | Clague et al. | Nov 2005 | B2 |
6960210 | Lands et al. | Nov 2005 | B2 |
6962587 | Johnson et al. | Nov 2005 | B2 |
6962589 | Mulier et al. | Nov 2005 | B2 |
6966907 | Goble | Nov 2005 | B2 |
6966909 | Marshall et al. | Nov 2005 | B2 |
6971988 | Orban et al. | Dec 2005 | B2 |
6974453 | Woloszko et al. | Dec 2005 | B2 |
6974454 | Hooven | Dec 2005 | B2 |
6976969 | Messerly | Dec 2005 | B2 |
6979332 | Adams | Dec 2005 | B2 |
6984231 | Goble et al. | Jan 2006 | B2 |
6984233 | Hooven | Jan 2006 | B2 |
6984826 | Miller et al. | Jan 2006 | B2 |
6989010 | Francischelli et al. | Jan 2006 | B2 |
6994705 | Nobis et al. | Feb 2006 | B2 |
6997735 | Ehr et al. | Feb 2006 | B2 |
6997935 | Anderson et al. | Feb 2006 | B2 |
7001380 | Goble | Feb 2006 | B2 |
7001415 | Hooven | Feb 2006 | B2 |
7011657 | Truckai et al. | Mar 2006 | B2 |
7025764 | Paton et al. | Apr 2006 | B2 |
7029470 | Francischelli et al. | Apr 2006 | B2 |
7033351 | Howell | Apr 2006 | B2 |
7033354 | Keppel | Apr 2006 | B2 |
7033356 | Latterell | Apr 2006 | B2 |
7041096 | Malis | May 2006 | B2 |
7041102 | Truckai et al. | May 2006 | B2 |
7044948 | Keppel | May 2006 | B2 |
7044949 | Orszulak | May 2006 | B2 |
7044950 | Yamamoto | May 2006 | B2 |
7048687 | Reuss et al. | May 2006 | B1 |
7049599 | Miller et al. | May 2006 | B2 |
7052494 | Goble et al. | May 2006 | B2 |
7060063 | Marion et al. | Jun 2006 | B2 |
7063699 | Hess | Jun 2006 | B2 |
7066933 | Hagg | Jun 2006 | B2 |
7066936 | Ryan | Jun 2006 | B2 |
7070597 | Truckai et al. | Jul 2006 | B2 |
7074218 | Washington et al. | Jul 2006 | B2 |
7074219 | Levine et al. | Jul 2006 | B2 |
7083618 | Couture et al. | Aug 2006 | B2 |
7083619 | Truckai et al. | Aug 2006 | B2 |
7083620 | Jahns et al. | Aug 2006 | B2 |
7087054 | Truckai et al. | Aug 2006 | B2 |
7090673 | Dycus | Aug 2006 | B2 |
7094202 | Nobis et al. | Aug 2006 | B2 |
7094235 | Francischelli | Aug 2006 | B2 |
7097644 | Long | Aug 2006 | B2 |
7101371 | Dycus et al. | Sep 2006 | B2 |
7101372 | Dycus et al. | Sep 2006 | B2 |
7101373 | Dycus et al. | Sep 2006 | B2 |
7103947 | Sartor et al. | Sep 2006 | B2 |
7104834 | Robinson et al. | Sep 2006 | B2 |
7104989 | Skarda | Sep 2006 | B2 |
7108695 | Witt et al. | Sep 2006 | B2 |
7111769 | Wales et al. | Sep 2006 | B2 |
7112201 | Truckai et al. | Sep 2006 | B2 |
RE39358 | Goble | Oct 2006 | E |
7116157 | Ross | Oct 2006 | B2 |
7118564 | Ritchie et al. | Oct 2006 | B2 |
7118570 | Tetzlaff et al. | Oct 2006 | B2 |
7118587 | Dycus et al. | Oct 2006 | B2 |
7119516 | Denning | Oct 2006 | B2 |
7124932 | Isaacson | Oct 2006 | B2 |
7125409 | Truckai et al. | Oct 2006 | B2 |
7126125 | Miller et al. | Oct 2006 | B2 |
7131445 | Amoah | Nov 2006 | B2 |
7131860 | Sartor | Nov 2006 | B2 |
7131970 | Moses et al. | Nov 2006 | B2 |
7131971 | Dycus et al. | Nov 2006 | B2 |
7135018 | Ryan et al. | Nov 2006 | B2 |
7135020 | Lawes et al. | Nov 2006 | B2 |
7137980 | Buysse | Nov 2006 | B2 |
D533942 | Kerr et al. | Dec 2006 | S |
7147635 | Ciarrocca | Dec 2006 | B2 |
7147637 | Goble | Dec 2006 | B2 |
7147638 | Chapman et al. | Dec 2006 | B2 |
7150097 | Sremcich | Dec 2006 | B2 |
7150748 | Ebbutt | Dec 2006 | B2 |
7150749 | Dycus et al. | Dec 2006 | B2 |
7153300 | Goble | Dec 2006 | B2 |
7156843 | Skarda | Jan 2007 | B2 |
7156845 | Mulier et al. | Jan 2007 | B2 |
7156846 | Dycus et al. | Jan 2007 | B2 |
7159750 | Racenet et al. | Jan 2007 | B2 |
7160293 | Sturm et al. | Jan 2007 | B2 |
7160298 | Lawes et al. | Jan 2007 | B2 |
7160299 | Baily | Jan 2007 | B2 |
7163548 | Stulen et al. | Jan 2007 | B2 |
7166105 | Mulier et al. | Jan 2007 | B2 |
7169115 | Nobis et al. | Jan 2007 | B2 |
7169144 | Hoey | Jan 2007 | B2 |
7169145 | Isaacson et al. | Jan 2007 | B2 |
7169146 | Truckai et al. | Jan 2007 | B2 |
7172591 | Harano et al. | Feb 2007 | B2 |
7179254 | Pendekanti | Feb 2007 | B2 |
7179258 | Buysse et al. | Feb 2007 | B2 |
7182604 | Ehr et al. | Feb 2007 | B2 |
7186252 | Nobis et al. | Mar 2007 | B2 |
7186253 | Truckai et al. | Mar 2007 | B2 |
7187790 | Sabol | Mar 2007 | B2 |
7189231 | Clague et al. | Mar 2007 | B2 |
7189232 | Scholl et al. | Mar 2007 | B2 |
7189233 | Truckai et al. | Mar 2007 | B2 |
7191015 | Lamson et al. | Mar 2007 | B2 |
7195627 | Amoah | Mar 2007 | B2 |
7195630 | Ciarrocca | Mar 2007 | B2 |
7195631 | Dumbauld | Mar 2007 | B2 |
7204835 | Latterell et al. | Apr 2007 | B2 |
7207471 | Heinrich et al. | Apr 2007 | B2 |
7207990 | Lands et al. | Apr 2007 | B2 |
D541938 | Kerr et al. | May 2007 | S |
7211081 | Goble | May 2007 | B2 |
7211084 | Goble | May 2007 | B2 |
7214224 | Goble | May 2007 | B2 |
7216001 | Hacker et al. | May 2007 | B2 |
7220260 | Fleming | May 2007 | B2 |
7220951 | Truckai et al. | May 2007 | B2 |
7223239 | Schulze et al. | May 2007 | B2 |
7223265 | Keppel | May 2007 | B2 |
7226447 | Uchida | Jun 2007 | B2 |
7229307 | Ehr et al. | Jun 2007 | B2 |
7232439 | Ciarrocca | Jun 2007 | B2 |
7232440 | Dumbauld et al. | Jun 2007 | B2 |
7235048 | Rein et al. | Jun 2007 | B2 |
7235072 | Sartor et al. | Jun 2007 | B2 |
7235073 | Levine et al. | Jun 2007 | B2 |
7237708 | Guy | Jul 2007 | B1 |
7241296 | Buysse et al. | Jul 2007 | B2 |
7247141 | Makin et al. | Jul 2007 | B2 |
7247155 | Hoey et al. | Jul 2007 | B2 |
7250048 | Francischelli et al. | Jul 2007 | B2 |
7250051 | Francischelli | Jul 2007 | B2 |
7252667 | Moses | Aug 2007 | B2 |
7255694 | Keppel | Aug 2007 | B2 |
7255696 | Goble et al. | Aug 2007 | B2 |
7255697 | Dycus et al. | Aug 2007 | B2 |
7259340 | Blaha et al. | Aug 2007 | B2 |
7261711 | Mulier et al. | Aug 2007 | B2 |
7267677 | Johnson et al. | Sep 2007 | B2 |
7270660 | Ryan | Sep 2007 | B2 |
7270664 | Johnson et al. | Sep 2007 | B2 |
7273483 | Weiner et al. | Sep 2007 | B2 |
7276068 | Johnson et al. | Oct 2007 | B2 |
7278994 | Goble | Oct 2007 | B2 |
7282048 | Goble et al. | Oct 2007 | B2 |
7282049 | Oraszulak et al. | Oct 2007 | B2 |
7291161 | Hooven | Nov 2007 | B2 |
7297145 | Woloszko et al. | Nov 2007 | B2 |
7300435 | Wham et al. | Nov 2007 | B2 |
7300446 | Beaupre | Nov 2007 | B2 |
7300450 | Vleugels et al. | Nov 2007 | B2 |
7303557 | Wham | Dec 2007 | B2 |
7309325 | Mulier et al. | Dec 2007 | B2 |
7309849 | Truckai et al. | Dec 2007 | B2 |
7311560 | Ehr et al. | Dec 2007 | B2 |
7311706 | Schoenman et al. | Dec 2007 | B2 |
7311707 | Hagg et al. | Dec 2007 | B2 |
7311709 | Truckai et al. | Dec 2007 | B2 |
7322975 | Goble et al. | Jan 2008 | B2 |
7329256 | Johnson et al. | Feb 2008 | B2 |
7335997 | Weiner | Feb 2008 | B2 |
7344532 | Goble et al. | Mar 2008 | B2 |
7347858 | Francischelli et al. | Mar 2008 | B2 |
RE40279 | Sluijter et al. | Apr 2008 | E |
D567943 | Moses et al. | Apr 2008 | S |
7353068 | Tanake et al. | Apr 2008 | B2 |
7354435 | Farin et al. | Apr 2008 | B2 |
7354440 | Truckai et al. | Apr 2008 | B2 |
7354443 | Moll et al. | Apr 2008 | B2 |
7364577 | Wham et al. | Apr 2008 | B2 |
7364578 | Francischelli et al. | Apr 2008 | B2 |
7364579 | Mulier et al. | Apr 2008 | B2 |
7367972 | Francischelli et al. | May 2008 | B2 |
7367976 | Lawes et al. | May 2008 | B2 |
7371246 | Viola | May 2008 | B2 |
7377902 | Burbank et al. | May 2008 | B2 |
7377918 | Amoah | May 2008 | B2 |
7377920 | Buysse et al. | May 2008 | B2 |
RE40388 | Gines | Jun 2008 | E |
7381209 | Truckai et al. | Jun 2008 | B2 |
7384420 | Dycus et al. | Jun 2008 | B2 |
7384421 | Hushka | Jun 2008 | B2 |
7396336 | Orszulak et al. | Jul 2008 | B2 |
D575395 | Hushka | Aug 2008 | S |
D575401 | Hixson et al. | Aug 2008 | S |
7416101 | Shelton | Aug 2008 | B2 |
7416437 | Sartor et al. | Aug 2008 | B2 |
7419487 | Johnson et al. | Sep 2008 | B2 |
7422139 | Shelton et al. | Sep 2008 | B2 |
7422588 | Mulier et al. | Sep 2008 | B2 |
7424965 | Racenet et al. | Sep 2008 | B2 |
7425835 | Eisele | Sep 2008 | B2 |
7426415 | Kuhner | Sep 2008 | B2 |
7431720 | Pendekanti et al. | Oct 2008 | B2 |
7431721 | Paton et al. | Oct 2008 | B2 |
7435249 | Buysse et al. | Oct 2008 | B2 |
7435250 | Francischelli et al. | Oct 2008 | B2 |
7442167 | Dunki-Jacobs | Oct 2008 | B2 |
7442193 | Shields | Oct 2008 | B2 |
7442194 | Dumbauld | Oct 2008 | B2 |
7445621 | Dumbauld et al. | Nov 2008 | B2 |
7458972 | Keppel | Dec 2008 | B2 |
7464846 | Shelton et al. | Dec 2008 | B2 |
7470272 | Mulier et al. | Dec 2008 | B2 |
7473250 | Makin et al. | Jan 2009 | B2 |
7473253 | Dycus et al. | Jan 2009 | B2 |
7476233 | Wiener et al. | Jan 2009 | B1 |
7481808 | Koyfman et al. | Jan 2009 | B2 |
7491199 | Goble et al. | Feb 2009 | B2 |
7497858 | Chapelon et al. | Mar 2009 | B2 |
20010037110 | Schmaltz | Nov 2001 | A1 |
20020052599 | Goble | May 2002 | A1 |
20020115997 | Truckai | Aug 2002 | A1 |
20020120262 | Bek | Aug 2002 | A1 |
20020120266 | Truckai et al. | Aug 2002 | A1 |
20020128650 | McClurken | Sep 2002 | A1 |
20020161363 | Fodor et al. | Oct 2002 | A1 |
20020165541 | Whitman | Nov 2002 | A1 |
20020188294 | Couture et al. | Dec 2002 | A1 |
20030004510 | Wham et al. | Jan 2003 | A1 |
20030014052 | Buysse et al. | Jan 2003 | A1 |
20030065327 | Wellman | Apr 2003 | A1 |
20030065358 | Frecker et al. | Apr 2003 | A1 |
20030069571 | Treat | Apr 2003 | A1 |
20030109871 | Johnson et al. | Jun 2003 | A1 |
20030114845 | Paton et al. | Jun 2003 | A1 |
20030114848 | Cobb | Jun 2003 | A1 |
20030114851 | Truckai et al. | Jun 2003 | A1 |
20030125731 | Smith et al. | Jul 2003 | A1 |
20030125734 | Mollenauer | Jul 2003 | A1 |
20030139741 | Goble et al. | Jul 2003 | A1 |
20030181910 | Dycus | Sep 2003 | A1 |
20030199863 | Swanson et al. | Oct 2003 | A1 |
20030199870 | Truckai et al. | Oct 2003 | A1 |
20030229344 | Dycus et al. | Dec 2003 | A1 |
20030236549 | Bonadio et al. | Dec 2003 | A1 |
20040006340 | Latterell | Jan 2004 | A1 |
20040068274 | Hooven | Apr 2004 | A1 |
20040068304 | Paton et al. | Apr 2004 | A1 |
20040073247 | Loshakove et al. | Apr 2004 | A1 |
20040092922 | Kadziauskas et al. | May 2004 | A1 |
20040122423 | Dycus | Jun 2004 | A1 |
20040162557 | Tetzlaff et al. | Aug 2004 | A1 |
20040193148 | Wham et al. | Sep 2004 | A1 |
20040215127 | Kadziauskas et al. | Oct 2004 | A1 |
20040225288 | Buysse et al. | Nov 2004 | A1 |
20040250419 | Sremich | Dec 2004 | A1 |
20050004563 | Racz et al. | Jan 2005 | A1 |
20050004564 | Wham et al. | Jan 2005 | A1 |
20050021027 | Shields et al. | Jan 2005 | A1 |
20050033282 | Hooven | Feb 2005 | A1 |
20050033352 | Zepf | Feb 2005 | A1 |
20050090815 | Francischelli et al. | Apr 2005 | A1 |
20050096681 | Desinger et al. | May 2005 | A1 |
20050101951 | Wham et al. | May 2005 | A1 |
20050107785 | Dycus | May 2005 | A1 |
20050113819 | Wham et al. | May 2005 | A1 |
20050124915 | Eggers et al. | Jun 2005 | A1 |
20050137592 | Nguyen et al. | Jun 2005 | A1 |
20050149017 | Dycus | Jul 2005 | A1 |
20050159745 | Truckai | Jul 2005 | A1 |
20050165444 | Hart | Jul 2005 | A1 |
20050192568 | Truckai et al. | Sep 2005 | A1 |
20050203504 | Wham | Sep 2005 | A1 |
20050234447 | Paton et al. | Oct 2005 | A1 |
20050245918 | Sliwa, Jr. et al. | Nov 2005 | A1 |
20050245922 | Goble | Nov 2005 | A1 |
20060020265 | Ryan | Jan 2006 | A1 |
20060041254 | Francischelli et al. | Feb 2006 | A1 |
20060052777 | Dumbauld | Mar 2006 | A1 |
20060079788 | Anderson | Apr 2006 | A1 |
20060079878 | Houser | Apr 2006 | A1 |
20060129146 | Dycus | Jun 2006 | A1 |
20060161190 | Gadberry et al. | Jul 2006 | A1 |
20060167450 | Johnson | Jul 2006 | A1 |
20060173453 | Gruhl | Aug 2006 | A1 |
20060217697 | Lau et al. | Sep 2006 | A1 |
20060217706 | Lau et al. | Sep 2006 | A1 |
20060217707 | Daniel et al. | Sep 2006 | A1 |
20060224152 | Behnke et al. | Oct 2006 | A1 |
20060224158 | Odom | Oct 2006 | A1 |
20060271042 | Latterell et al. | Nov 2006 | A1 |
20070016185 | Tullis et al. | Jan 2007 | A1 |
20070043352 | Garrison et al. | Feb 2007 | A1 |
20070043353 | Dycus | Feb 2007 | A1 |
20070062017 | Dycus et al. | Mar 2007 | A1 |
20070090788 | Hansford et al. | Apr 2007 | A1 |
20070093800 | Wham et al. | Apr 2007 | A1 |
20070123847 | Mihori | May 2007 | A1 |
20070135811 | Hooven | Jun 2007 | A1 |
20070142833 | Dycus | Jun 2007 | A1 |
20070142834 | Dumbauld | Jun 2007 | A1 |
20070156139 | Schecter | Jul 2007 | A1 |
20070156140 | Baily | Jul 2007 | A1 |
20070167941 | Hamel et al. | Jul 2007 | A1 |
20070173811 | Couture et al. | Jul 2007 | A1 |
20070173813 | Odom | Jul 2007 | A1 |
20070173814 | Hixson et al. | Jul 2007 | A1 |
20070179499 | Garrison | Aug 2007 | A1 |
20070191827 | Lischinsky et al. | Aug 2007 | A1 |
20070191828 | Houser et al. | Aug 2007 | A1 |
20070203481 | Gregg et al. | Aug 2007 | A1 |
20070213712 | Buysse et al. | Sep 2007 | A1 |
20070260242 | Dycus et al. | Nov 2007 | A1 |
20070276363 | Patton et al. | Nov 2007 | A1 |
20070282195 | Masini et al. | Dec 2007 | A1 |
20070282320 | Buysse et al. | Dec 2007 | A1 |
20070282332 | Witt et al. | Dec 2007 | A1 |
20070287997 | Tolmei | Dec 2007 | A1 |
20080009860 | Odom | Jan 2008 | A1 |
20080015563 | Hoey et al. | Jan 2008 | A1 |
20080015564 | Wham et al. | Jan 2008 | A1 |
20080030206 | Podhajsky et al. | Feb 2008 | A1 |
20080039831 | Odom et al. | Feb 2008 | A1 |
20080045947 | Johnson et al. | Feb 2008 | A1 |
20080058802 | Couture | Mar 2008 | A1 |
20080082098 | Tanaka et al. | Apr 2008 | A1 |
20080091189 | Carlton | Apr 2008 | A1 |
20080114356 | Johnson et al. | May 2008 | A1 |
20080125772 | Stone et al. | May 2008 | A1 |
20080132893 | D'Amelio et al. | Jun 2008 | A1 |
20080167651 | Tetzlaff et al. | Jul 2008 | A1 |
20080172048 | Martin | Jul 2008 | A1 |
20080188848 | Deutmeyer et al. | Aug 2008 | A1 |
20080208246 | Livneh | Aug 2008 | A1 |
20080215050 | Bakos | Sep 2008 | A1 |
20080215051 | Buysse et al. | Sep 2008 | A1 |
20080228179 | Eder et al. | Sep 2008 | A1 |
20080294222 | Schecter | Nov 2008 | A1 |
20080300589 | Paul et al. | Dec 2008 | A1 |
20080300590 | Horne et al. | Dec 2008 | A1 |
20080300591 | Darin et al. | Dec 2008 | A1 |
20090012520 | Hixson et al. | Jan 2009 | A1 |
20090024126 | Artale | Jan 2009 | A1 |
20090248007 | Falkenstein et al. | Oct 2009 | A1 |
20090275940 | Malackowski | Nov 2009 | A1 |
Number | Date | Country |
---|---|---|
4024636 | Feb 1992 | DE |
4024636 | Dec 1992 | DE |
10 2005 044 918 | Feb 2007 | DE |
315338 | May 1989 | EP |
538984 | Apr 1993 | EP |
570675 | Nov 1993 | EP |
598202 | May 1994 | EP |
0737447 | Oct 1996 | EP |
878168 | Nov 1998 | EP |
1054637 | Nov 2000 | EP |
1535581 | Jun 2005 | EP |
1545361 | Jun 2005 | EP |
1557129 | Jul 2005 | EP |
1634539 | Mar 2006 | EP |
1728475 | Dec 2006 | EP |
1810628 | Jul 2007 | EP |
1634539 | Feb 2008 | EP |
1665995 | Feb 2008 | EP |
1946715 | Jul 2008 | EP |
2 106 762 | Jul 2009 | EP |
2 156 802 | Feb 2010 | EP |
2157175 | Oct 1985 | GB |
60-30946 | Feb 1994 | JP |
83-17935 | Dec 1996 | JP |
11-070123 | Mar 1999 | JP |
11-070124 | Mar 1999 | JP |
11-178833 | Jul 1999 | JP |
2000-254135 | Sep 2000 | JP |
2003-135481 | May 2003 | JP |
2003-164463 | Jun 2003 | JP |
2006-109945 | Apr 2006 | JP |
2006-167403 | Jun 2006 | JP |
2007-144201 | Jun 2007 | JP |
2007-195980 | Aug 2007 | JP |
2007-195985 | Aug 2007 | JP |
2008-043789 | Feb 2008 | JP |
2008-259864 | Oct 2008 | JP |
WO9315662 | Aug 1993 | WO |
WO9710764 | Mar 1997 | WO |
WO9940857 | Aug 1999 | WO |
WO0112090 | Feb 2001 | WO |
WO2004030553 | Apr 2004 | WO |
WO2004032776 | Apr 2004 | WO |
WO2004032777 | Apr 2004 | WO |
WO2004082495 | Sep 2004 | WO |
WO2005004735 | Jan 2005 | WO |
WO2005053785 | Jun 2005 | WO |
WO 2006119245 | Nov 2006 | WO |
WO2006125558 | Nov 2006 | WO |
WO2007142601 | Dec 2007 | WO |
WO2008147773 | Dec 2008 | WO |
Entry |
---|
Bertil Vallfors and Bjorn Bergdahl, Automatically controlled bipolar electrocoagulation—“COA-COMP”, Neurosurg Rev., 1984, 187-190. |
European Patent Office, European Search Report for European Application No. EP 10 19 2593 dated Mar. 21, 2011, titled Electrosurgical System. |
European Patent Office, Partial European Search Report for European Application No. EP 10 19 2614 dated Apr. 18, 2011. |
International Searching Authority/US, International Search Report and Written Opinion for International Application No. PCT/US09/039046, entitled Electrosurgical System, mailed Jul. 27, 2009. |
European Patent Office, Extended European Search Report for European Application No. EP 10 19 2580 dated Jul. 21, 2011. |
“New Products” Journal of Medical Engineering and Technology, vol. 19, No. 5 (Sep./Oct. 1995), pp. 189-190. |
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US09/39046, titled “Electrosurgical System”, dated Mar. 26, 2010. |
Co-Pending U.S. Appl. No. 12/416,128, filed Mar. 31, 2009, entitled “Electrosurgical System”. |
Co-Pending U.S. Appl. No. 12/416,668, filed Apr. 1, 2009, entitled “Electrosurgical System”. |
Co-Pending U.S. Appl. No. 12/416,751, filed Apr. 1, 2009, entitled “Electrosurgical System”. |
Co-Pending U.S. Appl. No. 12/416,695, filed Apr. 1, 2009, entitled “Electrosurgical System”. |
International Preliminary Examining Authority, International Preliminary Report on Patentability for International Application No. PCT/US2009/39046 dated Jan. 17, 2012. |
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2011/054661, mailed Mar. 6, 2012. |
European Patent Office, European Search Report for European Application No. EP 13 17 4814.7 dated Sep. 30 2013, titled Electrosurgical System. |
Number | Date | Country | |
---|---|---|---|
20090248013 A1 | Oct 2009 | US |
Number | Date | Country | |
---|---|---|---|
61040980 | Mar 2008 | US | |
61040994 | Mar 2008 | US | |
61040957 | Mar 2008 | US | |
61040828 | Mar 2008 | US | |
61040890 | Mar 2008 | US | |
61041045 | Mar 2008 | US | |
61041012 | Mar 2008 | US | |
61115756 | Nov 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12416128 | Mar 2009 | US |
Child | 12416765 | US |